Synopsis
0
EU WC
0
NDC API
0
VMF
0
Australia
DRUG PRODUCT COMPOSITIONS
0
US Patents
0
US Exclusivities
0
Health Canada Patents
US Medicaid
NA
Annual Reports
NA
Regulatory FDF Prices
NA
0
FDF
0
Stock Recap #PipelineProspector
0
Weekly News Recap #Phispers


1. Absolute Alcohol
2. Alcohol, Absolute
3. Alcohol, Ethyl
4. Alcohol, Grain
5. Ethyl Alcohol
6. Grain Alcohol
1. Ethyl Alcohol
2. Alcohol
3. 64-17-5
4. Grain Alcohol
5. Methylcarbinol
6. Ethyl Hydroxide
7. Ethyl Hydrate
8. Tecsol
9. Etoh
10. Algrain
11. Anhydrol
12. Hydroxyethane
13. Alkohol
14. Jaysol S
15. Potato Alcohol
16. Cologne Spirit
17. 1-hydroxyethane
18. Absolute Ethanol
19. Ethanol 200 Proof
20. Molasses Alcohol
21. Spirits Of Wine
22. Etanol
23. Aethylalkohol
24. Denatured Alcohol
25. Denatured Ethanol
26. Aethanol
27. Alcool Ethylique
28. Fermentation Alcohol
29. Alcohol, Diluted
30. Tecsol C
31. Dehydrated Ethanol
32. Alcool Etilico
33. Alcohol, Ethyl
34. Alcohols
35. Etanolo
36. Jaysol
37. Etylowy Alkohol
38. Absolute Alcohol
39. Ethanol Solution
40. Alcohol Dehydrated
41. Alkoholu Etylowego
42. Dehydrated Alcohol
43. Ethyl Alcohol Usp
44. Alcohol, Anhydrous
45. Synasol
46. Ethyl Alcohol Anhydrous
47. Denatured Alcohol Cd-5
48. Denatured Alcohol Sd-1
49. Alcohol Anhydrous
50. Distilled Spirits
51. Denatured Alcohol Cd-5a
52. Denatured Alcohol Sd-3a
53. Denatured Alcohol Cd-10
54. Denatured Alcohol Sd-17
55. Denatured Alcohol Sd-28
56. Denatured Alcohol Sd-30
57. Denatured Alcohol Sd-13a
58. Denatured Alcohol Sd-23a
59. Denatured Alcohol Sd-39b
60. Denatured Alcohol Sd-39c
61. Denatured Alcohol Sd-40m
62. Ethylalcohol
63. Spirit
64. Alcohol, Dehydrated
65. Sd Alchol 23-hydrogen
66. Alkohol [german]
67. Aethanol [german]
68. Etanolo [italian]
69. Ethyl Alcohol & Water, 5%
70. Thanol
71. Ethanol, Undenatured
72. Spirt
73. Alcare Hand Degermer
74. Ethyl Alcohol & Water, 10%
75. Ethyl Alcohol & Water, 20%
76. Ethyl Alcohol & Water, 30%
77. Ethyl Alcohol & Water, 40%
78. Ethyl Alcohol & Water, 50%
79. Ethyl Alcohol & Water, 60%
80. Ethyl Alcohol & Water, 70%
81. Ethyl Alcohol & Water, 80%
82. Ethyl Alcohol & Water, 95%
83. Ethyl Alcohol & Water, 96%
84. Ethyl Alc
85. Ethylalcohol [dutch]
86. Ethyl Alcohol And Water
87. Alcohol, Absolute
88. Nci-c03134
89. Alcohol (ethyl Alcohol)
90. Alcohol [usp]
91. Ethanol [jan]
92. Ethicap
93. Hinetoless
94. Alcohols, C1-3
95. Cologne Spirits
96. Caswell No. 430
97. Reagent Alcohol
98. Infinity Pure
99. Aethylalkohol [german]
100. Desinfektol El
101. Anhydrous Alcohol
102. Anhydrous Ethanol
103. Ethyl Alcohol In Alcoholic Beverages
104. Fema No. 2419
105. Fema Number 2419
106. Alcool Etilico [italian]
107. Etylowy Alkohol [polish]
108. Ethyl Alcohol, Undenatured
109. Alcool Ethylique [french]
110. C2h5oh
111. Alkoholu Etylowego [polish]
112. Hsdb 82
113. Sdm No. 37
114. Ai3-01706
115. Ccris 945
116. Ethylicum
117. Alcohol,ethyl
118. Edible Alcohol
119. Ethanol Vapor
120. Sd Alcohol 23-hydrogen
121. Alcohol Denatured
122. Alcohol,dehydrated
123. Ru-tuss Hydrocodone Liquid
124. Alcohol, Denatured
125. Ethanol, Denatured
126. Ethanol, Anhydrous
127. Nsc 85228
128. Ethanol, Dehydrated
129. Alcohol (usp)
130. Epa Pesticide Chemical Code 001501
131. Absolute Ethyl Alcohol
132. Ethyl Alcohol, Absolute
133. Punctilious Ethyl Alcohol
134. Ethyl Alcohol, Dehydrated
135. Ethanol Absolute
136. Ethanol, Anhydrous, Denatured
137. Alcohol Determination--alcohol
138. Chebi:16236
139. Nsc-85228
140. 3k9958v90m
141. Ethanol, Cda 19
142. Ethanol, 200 Proof
143. Ethyl Alcohol Denatured
144. Ethylol
145. Pm-6193-200
146. Ethanol Anhydrous
147. 68475-56-9
148. Eoh
149. Sekundasprit
150. Alcohol Etilico
151. Spiritus Vini
152. Mfcd00003568
153. Ethanol Denatured
154. 42845-45-4
155. Lux
156. Sy Fresh M
157. Esumiru Wk 88
158. Ethanol (9ci)
159. Ethanol, Silent Spirit
160. Alcohol Denat.
161. Anhydrol Pm 4085
162. Ethyl Alcohol, Anhydrous
163. Ethyl Alcohol (ethanol)
164. Higher Alcohol Distillate
165. Alcohol 5% In Dextrose 5%
166. Einecs 200-578-6
167. Cologne Spirits (alcohol)
168. Sda 3a
169. Alcoholum
170. Ethanolum
171. Silent Spirit
172. Diluted Alcohol
173. Ethanol In Alcoholic Beverages
174. Vodka
175. Alcohol,sda
176. Ethanol-
177. 100c.npa
178. Cda 19
179. Ims 99
180. Sd Alcohol
181. Ethanol, Dimer
182. Alcohol,denatured
183. Unii-3k9958v90m
184. Alcohol (ethyl)
185. Undenatured Ethanol
186. Ahd 2000
187. Sda 40-2
188. Vanilla Powder
189. Einecs 270-649-4
190. Eosin Y, Alcoholic
191. Ablysinol
192. Alcohol 95%
193. Alcohol 190 Proof
194. Cda 19-200
195. Ethyl Alcohol 40%
196. Ethyl Alcohol 70%
197. Ethyl Alcohol 75%
198. Ethyl Alcohol 80%
199. Ethyl Alcohol 90%
200. Alcohol [vandf]
201. Alcohol [hsdb]
202. Alcohol [inci]
203. Ethanol, 99.8%
204. Ethanol, Technical Grade
205. Fatty Alcohol C8-10
206. Reagent Alcohol, 70%
207. Reagent Alcohol, 80%
208. Reagent Alcohol, 95%
209. Alcohol [ii]
210. Ch3ch2oh
211. Dehydrated Ethanol (tn)
212. Ethyl Alcohol 47.5%
213. Ethylicum [hpus]
214. Dsstox_cid_584
215. Ethanol, Standard For Gc
216. Alcohol [usp-rs]
217. Alcohol [who-ip]
218. Ethanol [who-dd]
219. Ethanol [who-ip]
220. Industrial Alcohol (ims)
221. Bmse000297
222. Chembl545
223. Ec 200-578-6
224. Ethanol, >=99.5%
225. Aerosol™ Ot Solution
226. Anhydrous Ethanol (jp17)
227. Ethyl Alcohol [mi]
228. Reagent Alcohol, For Hplc
229. Ethanol, Analytical Standard
230. Dsstox_rid_75674
231. Sd 3a
232. Dsstox_gsid_20584
233. Ru-tuss Liquid (salt/mix)
234. Ethanol, Usp, 99.5%
235. Ethyl Alcohol [fhfi]
236. Wln: Q2
237. Ethanol, For Residue Analysis
238. Reagent Alcohol, Acs Reagent
239. Alcohol [orange Book]
240. Alcohol,ethyl [vandf]
241. B3324 [langual]
242. Duplicating Fluid 100c.npa
243. Ethanol, P.a., 99.8%
244. Reagent Alcohol, Reagent Grade
245. Sdm No. 37 (salt/mix)
246. Gtpl2299
247. Anhydrous Ethanol [jan]
248. Avagard Component Alcohol
249. Hbn-1 Component Ethanol
250. Alcohol Dehydrated, >=85.0%
251. Dtxsid9020584
252. Ethanol, Technical Grade, 93%
253. Ethanol, Technical Grade, 99%
254. Unii-7528n5h79b
255. Chebi:17246
256. Ethanol, 95.1-96.9%
257. Poly(vinyl Alcohol) Macromolecule
258. Ru-tuss Expectorant (salt/mix)
259. Alcohol, Dehydrated [ii]
260. Alcoholum [who-ip Latin]
261. Ethanolum [who-ip Latin]
262. Ethyl Alcohol (6ci,7ci,8ci)
263. Alcohol,dehydrated [vandf]
264. Ethanol Component Of Hbn-1
265. Ethanol, Technical Grade, 93.8%
266. Ethanol, Technical Grade, 99.5%
267. Alcohol Component Of Avagard
268. Alcohol, Dehydrated [vandf]
269. Dehydrated Alcohol [usp-rs]
270. Ethanol, >=99.5%, For Hplc
271. Nsc85228
272. Str05604
273. Ethanol 100 Microg/ml In Methanol
274. Ethyl Alcohol 95% Acs/usp Grade
275. Tox21_202510
276. Stl264245
277. Ethanol 1000 Microg/ml In Methanol
278. Ethanol 2000 Microg/ml In Methanol
279. Ethanol, 95.0%, (190 Proof)
280. Ethanol, P.a., Acs Reagent, 96%
281. Ethanol, Tested According To Ph.eur.
282. Ethanol, Usp, 70.0-72.0%
283. Ethanol, Usp, 94.9-96.0%
284. Akos009104571
285. Ethanol, Reagent (denatured Sda 3a)
286. 7528n5h79b
287. Db00898
288. Ethanol 10000 Microg/ml In Methanol
289. Ethanol, Absolute, >=99.8% (gc)
290. Ethanol, Uv Hplc Spectroscopic, 95%
291. Un 1170
292. Cas-64-17-5
293. Ethanol, Denatured, (uk Ida Standard)
294. Ethanol, Saj First Grade, >=99.5%
295. Ethyl Alcohol Absolute, Acs/usp Grade
296. Ethanol, Jis Special Grade, >=99.5%
297. Ethanol, P.a., Acs Reagent, 95.0%
298. Ethanol, Technical Grade, 92.6-93.8
299. Ncgc00091458-01
300. Ncgc00091458-02
301. Ncgc00260059-01
302. Reagent Alcohol, Spectrophotometric Grade
303. Dehydrated Alcohol [usp Monograph]
304. Ethanol, Anhydrous [ep Monograph]
305. Q153
306. Ethanol, Absolute, For Hplc, >=99.8%
307. Ethanol, Anhydrous, Denatured, Hplc Grade
308. Ethyl Alcohol 95% (synthetic) Fcc Grade
309. Ethanol, Acs Reagent, 99.8, 200 Proof
310. Ethanol, Jis First Grade, 94.8-95.8%
311. Ethyl Alcohol Absolute (organic) Usp Grade
312. E1510
313. Ethanol In Alcoholic Beverages [iarc]
314. Ethanol Solution, Ep, Bp, 69.5-70.4%
315. Ethanol, Denatured, Spectrophotometric Grade
316. Ethanol, Jis Special Grade, 94.8-95.8%
317. Ft-0625729
318. Ft-0625731
319. Ft-0625732
320. Ft-0668048
321. Ethanol, >=99.5%, Saj Super Special Grade
322. Reagent Alcohol, Anhydrous, <=0.003% Water
323. Reagent Alcohol, Anhydrous, <=0.005% Water
324. C00469
325. D00068
326. Ethanol, >=99.5%, Suitable For Fluorescence
327. Ethanol, Alcohol Reagent, Anhydrous, Denatured
328. Ethyl Alcohol 95% (grain Derived) Fcc Grade
329. Ethyl Alcohol 95% (synthetic) Acs/usp Grade
330. Ethyl Alcohol Absolute (synthetic) Acs/usp Grade
331. Sr-01000944357
332. Ethanol, Puriss. P.a., Absolute, >=99.8% (gc)
333. Sr-01000944357-1
334. Ethanol, Denatured (5 % Ipa, 5 % N-propylacetate)
335. Reagent Alcohol, Used For Histology Tissue Preparation
336. Ethanol, Anhydrous, Denatured, Spectrophotometric Grade
337. Ethyl Alcohol, Pure, 190 Proof, For Molecular Biology
338. Ethyl Alcohol, Pure, 200 Proof, Anhydrous, >=99.5%
339. Ethyl Alcohol, Pure, 200 Proof, For Molecular Biology
340. Ethanol 70%, Denatured With 1% Mek, 1% Ipa, 10 Mg/l
341. Ethanol, Absolute, >=99.8% (gc), Sales Not In Germany
342. Ethyl Alcohol Absolute (dehydrated) Usp, Bp/ep, Jp Grade
343. Ethyl Alcohol, Pure, 200 Proof, Acs Reagent, >=99.5%
344. Reagent Alcohol, 70%, Used For Histology Tissue Preparation
345. Reagent Alcohol, 80%, Used For Histology Tissue Preparation
346. 1e37b0d2-6209-4b03-a57d-500f3223c2da
347. Alcohol, United States Pharmacopeia (usp) Reference Standard
348. Ethanol, >=99.5%, Suitable For Absorption Spectrum Analysis
349. Ethanol-water Solutions, Nist(r) Srm(r) 1828b, Six Levels
350. Ethyl Alcohol, Pure, 200 Proof, Hplc/spectrophotometric Grade
351. Reagent Alcohol, 95%, Used For Histology Tissue Preparation
352. Ethanol Solution, Nist(r) Srm(r) 2897a, Nominal Mass Fraction 2%
353. Ethanol Solution, Nist(r) Srm(r) 2898a, Nominal Mass Fraction 6%
354. Ethanol Solution, Nist(r) Srm(r) 2899a, Nominal 25% By Mass
355. Ethanol, P.a., Acs Reagent, Reag. Iso, Reag. Ph. Eur., 99.9%
356. Ethanol, Suitable For 300 Per Jis, >=99.5%, For Residue Analysis
357. Ethyl Alcohol, Pure, 190 Proof, Meets Usp Testing Specifications
358. Ethyl Alcohol, Pure, 200 Proof, Anhydrous, Zero2(tm), >=99.5%
359. Ethyl Alcohol, Pure, 200 Proof, Meets Usp Testing Specifications
360. Specially Denatured Alcohol, 190 Proof, Sda 23a, Contains Acetone
361. Specially Denatured Alcohol, 190 Proof, Sda 2b-3, Contains Toluene
362. Specially Denatured Alcohol, 190 Proof, Sda 30, Contains Methanol
363. Specially Denatured Alcohol, 190 Proof, Sda 3a, Contains Methanol
364. Specially Denatured Alcohol, 200 Proof, Sda 23a, Contains Acetone
365. Specially Denatured Alcohol, 200 Proof, Sda 2b-3, Contains Toluene
366. Specially Denatured Alcohol, 200 Proof, Sda 30, Contains Methanol
367. Specially Denatured Alcohol, 200 Proof, Sda 3a, Contains Methanol
368. Alcohol, Pharmaceutical Secondary Standard; Certified Reference Material
369. Dehydrated Alcohol, United States Pharmacopeia (usp) Reference Standard
370. Ethanol Fixative 80% V/v, Suitable For Fixing Solution (blood Films)
371. Ethanol Solution, Certified Reference Material, 2000 Mug/ml In Methanol
372. Ethanol Standards 10% (v/v), 10 % (v/v) In H2o, Analytical Standard
373. Ethanol, Absolute, For Gradient Elution, Sales Not In Germany, >=99.9%
374. Ethanol, Absolute, For Hplc, Sales Not In Germany1, >=99.8% (gc)
375. Ethanol, Absolute, Semiconductor Grade Puranal(tm) (honeywell 17826)
376. Ethanol, Suitable For 1000 Per Jis, >=99.5%, For Residue Analysis
377. Ethanol-water Solution, Nist(r) Srm(r) 2894, Nominal Mass Fraction 0.1%
378. Ethanol-water Solution, Nist(r) Srm(r) 2895, Nominal Mass Fraction 0.2%
379. Ethanol-water Solution, Nist(r) Srm(r) 2896, Nominal Mass Fraction 0.3%
380. Ethanol-water Solution, Nist(r) Srm(r) 2900, Nominal 95.6% By Mass
381. Ethyl Alcohol Absolute (dehydrated, Synthetic) Usp, Bp/ep, Jp Grade
382. Ethyl Alcohol, Pure, 140 Proof, Excise Tax-free, Permit For Use Required
383. Ethyl Alcohol, Pure, 160 Proof, Excise Tax-free, Permit For Use Required
384. Ethyl Alcohol, Pure, 190 Proof, Acs Spectrophotometric Grade, 95.0%
385. Specially Denatured Alcohol, 190 Proof, Sda 2b-4, Contains Heptanes
386. Specially Denatured Alcohol, 190 Proof, Sda 2b-4, Contains N-heptane
387. Specially Denatured Alcohol, 190 Proof, Sda 2b-5, Contains N-hexane
388. Specially Denatured Alcohol, 190 Proof, Sda 35a, Contains Ethyl Acetate
389. Specially Denatured Alcohol, 190 Proof, Sda 3c, Contains Isopropanol
390. Specially Denatured Alcohol, 200 Proof, Sda 2b-4, Contains Heptanes
391. Specially Denatured Alcohol, 200 Proof, Sda 2b-4, Contains N-heptane
392. Specially Denatured Alcohol, 200 Proof, Sda 2b-5, Contains N-hexane
393. Specially Denatured Alcohol, 200 Proof, Sda 35a, Contains Ethyl Acetate
394. Specially Denatured Alcohol, 200 Proof, Sda 3c, Contains Isopropanol
395. Alcohol Determination-alcohol, United States Pharmacopeia (usp) Reference Standard
396. Dehydrated Alcohol, Pharmaceutical Secondary Standard; Certified Reference Material
397. Ethanol Calibration Kit, Ampule Of 10 X 1.2 Ml, Certified Reference Material
398. Ethanol, Absolute, Reag. Iso, Reag. Ph. Eur., >=99.8% (gc), Liquid (clear, Colorless)
399. Ethanol, Puriss. P.a., Acs Reagent, Absolute Alcohol, Without Additive, A15 O1, >=99.8%
400. Ethanol, Puriss. P.a., Acs Reagent, Prima Fine Spirit, Without Additive, F15 O1, ~96%
401. Ethanol, Puriss., Meets Analytical Specification Of Ph.??eur., Bp, 96% (v/v)
402. Ethanol, Puriss., Meets Analytical Specification Of Ph.??eur., Bp, 96.0-97.2%
403. Ethanol-10, 10 Mg/dl In H2o, Pack Of 10 X 1.2 Ml Ampules, Certified Reference Material
404. Ethanol-150, 150 Mg/dl In H2o, Ampule Of 10 X 1.2 Ml, Certified Reference Material
405. Ethanol-25, 25 Mg/dl In H2o, Ampule Of 10 X 1.2 Ml, Certified Reference Material
406. Ethanol-300, 300 Mg/dl In H2o, Ampule Of 10 X 1.2 Ml, Certified Reference Material
407. Ethanol-40, 40 Mg/dl In H2o, Ampule Of 10 X 1.2 Ml, Certified Reference Material
408. Ethanol-50, 50 Mg/dl In H2o, Ampule Of 10 X 1.2 Ml, Certified Reference Material
409. Ethanol-500, 500 Mg/dl In H2o, Ampule Of 10 X 1.2 Ml, Certified Reference Material
410. Ethanol-80, 80 Mg/dl In H2o, Ampule Of 10 X 1.2 Ml, Certified Reference Material
411. Ethanol-80, 80 Mg/dl In H2o, Ampule Of 5 X 5 Ml, Certified Reference Material
412. Ethanol-water Solution, Nist(r) Srm(r) 2891, Nominal Mass Fraction 0.02%
413. Ethanol-water Solution, Nist(r) Srm(r) 2892, Nominal Mass Fraction 0.04%
414. Ethanol-water Solution, Nist(r) Srm(r) 2893, Nominal Mass Fraction 0.08%
415. Specially Denatured Alcohol, 190 Proof, Sda 39c, Contains Diethyl Phthalate
416. Specially Denatured Alcohol, 200 Proof, Sda 39c, Contains Diethyl Phthalate
417. Ethanol, Absolute, Denaturated With 0.5-1.5 Vol.% 2-butanone And Approx. 0.001% Bitrex (gc), >=98% (gc)
418. Ethanol, Absolute, Semiconductor Grade Puranal(tm) (honeywell 17833), Sales Not In Germany, >=99.8% (vol.)
419. Ethanol, Bioultra, For Molecular Biology, >=99.8%, (absolute Alcohol, Without Additive, A15 O1)
420. Ethanol, Puriss., Over Molecular Sieve (h2o <=0.01%), Absolute Alcohol, Without Additive, A15 O1, >=99.8%
421. Ethanol, Purum, Absolute Ethanol, Denaturated With 1% Cyclohexane, A15 Cyclo1, >=99.8% (based On Denaturant-free Substance)
422. Ethanol, Purum, Absolute Ethanol, Denaturated With 2% 2-butanone, A15 Mek1, >=99.8% (based On Denaturant-free Substance)
423. Ethanol, Purum, Absolute Ethanol, Denaturated With 4.8% Isopropanol, A15 Ipa1, >=99.8% (based On Denaturant-free Substance)
424. Ethanol, Purum, Fine Spirit, Denaturated With 2% 2-butanone, F25 Mek1, ~96% (based On Denaturant-free Substance)
425. Ethanol, Purum, Fine Spirit, Denaturated With 4.8% Methanol, F25 Methyl1, ~96% (based On Denaturant-free Substance)
426. Ethanol, Purum, Secunda Spirit, Denaturated With 2% 2-butanone And 0.5% 4-methyl-2-pentanone, S15, ~96% (based On Denaturant-free Substance)
427. Ethanol-100 (10 Ampules/kit), 100 Mg/dl In H2o, Ampule Of 10 X 1.2 Ml, Certified Reference Material
428. Ethanol-100 (5 Ampules/kit), 100 Mg/dl In H2o, Ampule Of 5 X 5 Ml, Certified Reference Material
429. Ethanol-20 (10 Ampules/kit), 20 Mg/dl In H2o, Ampule Of 10 X 1.2 Ml, Certified Reference Material
430. Ethanol-20 (5 Ampules/kit), 20 Mg/dl In H2o, Ampule Of 5 X 5 Ml, Certified Reference Material
431. Ethanol-200 (10 Ampules/kit), 200 Mg/dl In H2o, Ampule Of 10 X 1.2 Ml, Certified Reference Material
432. Ethanol-200 (5 Ampules/kit), 200 Mg/dl In H2o, Ampule Of 5 X 5 Ml, Certified Reference Material
433. Ethanol-400 (10 Ampules/kit), 400 Mg/dl In H2o, Ampule Of 10 X 1.2 Ml, Certified Reference Material
434. Ethanol-400 (5 Ampules/kit), 400 Mg/dl In H2o, Ampule Of 5 X 5 Ml, Certified Reference Material
435. Ethyl Alcohol, Pure, 140 Proof, Meets Water Usp Testing Specifications, Excise Tax-free, Permit For Use Required
436. Ethyl Alcohol, Pure, 190 Proof, Acs Reagent, Meets Usp Testing Specifications, Excise Tax-free, Permit For Use Required
437. Ethyl Alcohol, Pure, 200 Proof, Acs Reagent, Meets Usp Testing Specifications, Excise Tax-free, Permit For Use Required
438. Specially Denatured Alcohol, 190 Proof, Sda 40 (40-2), Contains 0.14 % (v/v) Tert-butyl Alcohol And Brucine Sulfate
439. Specially Denatured Alcohol, 190 Proof, Sda 40b, Contains Tert-butyl Alcohol And Denatonium Benzoate
440. Specially Denatured Alcohol, 200 Proof, Sda 40 (40-2), Contains 0.14 % (v/v) Tert-butyl Alcohol And Brucine Sulfate
441. Specially Denatured Alcohol, 200 Proof, Sda 40b, Contains Tert-butyl Alcohol And Denatonium Benzoate
| Molecular Weight | 46.07 g/mol |
|---|---|
| Molecular Formula | C2H6O |
| XLogP3 | -0.1 |
| Hydrogen Bond Donor Count | 1 |
| Hydrogen Bond Acceptor Count | 1 |
| Rotatable Bond Count | 0 |
| Exact Mass | 46.041864811 g/mol |
| Monoisotopic Mass | 46.041864811 g/mol |
| Topological Polar Surface Area | 20.2 Ų |
| Heavy Atom Count | 3 |
| Formal Charge | 0 |
| Complexity | 2.8 |
| Isotope Atom Count | 0 |
| Defined Atom Stereocenter Count | 0 |
| Undefined Atom Stereocenter Count | 0 |
| Defined Bond Stereocenter Count | 0 |
| Undefined Bond Stereocenter Count | 0 |
| Covalently Bonded Unit Count | 1 |
/EXPL THER/ Ethanol lock therapy (ELT) has emerged as an effective method for the prevention and treatment of central line-associated bloodstream infections (CLABSIs), but the safety of ELT in infants has not been established. The objective of this study was to determine blood alcohol concentration (BAC) and evidence of hepatic injury in infants after infusing a small one-time dose of ethanol, equivalent to the volume that would be flushed through the central venous catheter (CVC) after ELT is completed. This was a prospective pilot study in infants weighing =6 kg with and without liver dysfunction who had a CVC. The primary end points were 5-minute and 1-hour BACs after a 0.4-mL dose of 70% ethanol was flushed through the CVC. Acceptable BACs were defined as <0.025% at 5 minutes and <0.01% at 1 hour. The secondary end point was evidence of hepatic injury, defined as a change of greater than 2 times the upper limit of normal of any component in the hepatic panel in patients with a normal baseline panel or doubling of any component in the hepatic panel in patients with an abnormal baseline panel (aspartate aminotransferase, alanine transaminase, total or direct bilirubin, gamma-glutamyl transferase, or alkaline phosphatase). A total of 10 patients were included for analysis, with a mean age and weight of 3.5 +/- 2.4 months and 4.5 +/- 0.9 kg, respectively. All patients had acceptable BACs and no evidence of hepatic injury. In 8 patients, 5-minute BACs were undetectable; BACs of the other 2 patients were 0.011%. One-hour BACs in all patients were undetectable. Flushing ELT resulted in acceptable BACs and no evidence of hepatic injury in this patient cohort. Further studies are needed to investigate the long-term safety and efficacy of ethanol infusion after ELT in this patient population for the prevention and treatment of CLABSIs.
PMID:25632063 Chhim RF et al; Ann Pharmacother 49 (4): 431-6 (2015)
/The objective of the study was/ to evaluate the efficacy, safety, pain perception and health-related quality of life (QoL) of percutaneous ethanol injection treatment (PEIT) as an alternative to thyroid surgery in symptomatic thyroid cysts. Thirty consecutive patients (46 +/- 10 years; 82% women) with symptomatic benign thyroid cysts relapsed after drainage were included. In all cases, cytology prior to treatment, maximum cyst diameter and volume were determined. PEIT was conducted using the established procedure, and the volume of fluid removed and pain perceived by the patient were assessed. In each procedure, the volume of alcohol instilled was <2 mL. After follow-up, final cyst diameter and volume were determined and the persistence of symptoms and QoL were assessed by a questionnaire (SF-36). Mean symptom duration was 10 +/- 20 months. A single session of PEIT was required to complete the procedure in 45% of patients, two in 31% and three in 13%. Mean initial maximum cyst diameter was 3.5 +/- 1.0 cm and mean extracted liquid volume 61 +/- 36 mL. During PEIT, 39% of patients experienced virtually no pain, 43% mild pain and 17% moderate pain. No complications of PEIT were observed. After 12.1 +/- 1.4 months of follow-up, cysts were reduced more than 70% in volume in 86.3% of patients, more than 80% in 61.9% and more than 90% in 42%. On the health-related QoL SF-36 questionnaire, patient scores 6 months post-PEIT did not differ significantly from those of the healthy Spanish population. With respect to cosmetic complaints or local symptoms of compression, PEIT-treated patients presented an initial score of 22 +/- 8 and 13 +/- 5 after treatment (p < 0.05). In our experience, percutaneous ethanol injection has proved to be an effective, safe and well-tolerated first-line treatment of symptomatic thyroid cysts.
PMID:26610707 Full text: https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4661972 Reverter JL et al; BMC Endocr Disord 15: 73 (2015)
Because of the increased risk of surgery, thyroid nodules causing compression signs and/or hyperthyroidism are concerning during pregnancy. Six patients with nontoxic cystic, four with nontoxic solid, and three with overt hyperthyroidism caused by toxic nodules were treated with percutaneous ethanol injection therapy (PEI). An average of 0.68 mL ethanol per 1 mL nodule volume was administered. Mean number of PEI treatments for patients was 2.9. Success was defined as the shrinkage of the nodule by more than 50% of the pretreatment volume (V0) and the normalization of TSH and FT4 levels. The average V0 was 15.3 mL. Short-term success was measured prior to labor, whereas long-term success was determined during the final follow-up (an average of 6.8 years). The pressure symptoms decreased in all but one patient after PEI and did not worsen until delivery. The PEI was successful in 11 (85%) and 7 (54%) patients at short-term and long-term follow-up, respectively. Three patients underwent repeat PEI which was successful in 2 patients. PEI is a safe tool and seems to have good short-term results in treating selected symptomatic pregnant patients. Long-term success may require repeat PEI.
PMID:26697066 Full text: https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4677206 Solymosi T et al; Int J Endocrinol 2015: 765950 (2015)
Methanol poisoning outbreaks are a global public health issue, with delayed treatment causing poor outcomes. Out-of-hospital ethanol administration may improve outcome, but the difficulty of conducting research in outbreaks has meant that its effects have never been assessed. We study the effect of out-of-hospital ethanol in patients treated during a methanol outbreak in the Czech Republic between 2012 and 2014. This was an observational case-series study of 100 hospitalized patients with confirmed methanol poisoning. Out-of-hospital ethanol as a "first aid antidote" was administered by paramedic or medical staff before the confirmation of diagnosis to 30 patients; 70 patients did not receive out-of-hospital ethanol from the staff (12 patients self-administered ethanol shortly before presentation). The state of consciousness at first contact with paramedic or medical staff, delay to admission, and serum methanol concentration were similar among groups. The median serum ethanol level on admission in the patients with out-of-hospital administration by paramedic or medical staff was 84.3 mg/dL (interquartile range 32.7 to 129.5 mg/dL). No patients with positive serum ethanol level on admission died compared with 21 with negative serum ethanol level (0% versus 36.2%). Patients receiving out-of-hospital ethanol survived without visual and central nervous system sequelae more often than those not receiving it (90.5% versus 19.0%). A positive association was present between out-of-hospital ethanol administration by paramedic or medical staff, serum ethanol concentration on admission, and both total survival and survival without sequelae of poisoning. We found a positive association between out-of-hospital ethanol administration and improved clinical outcome. During mass methanol outbreaks, conscious adults with suspected poisoning should be considered for administration of out-of-hospital ethanol to reduce morbidity and mortality.
PMID:26875060 Zakharov S et al; Ann Emerg Med 68 (1): 52-61 (2016)
For more Therapeutic Uses (Complete) data for Ethanol (24 total), please visit the HSDB record page.
Although there is a dose response relationship between alcohol consumption and liver damage, less than one-third of alcoholics develop alcoholic liver disease (ALD). This individual susceptibility to the development of alcoholic liver disease may be explained by genetic and environmental factors. Of the genetic factors, female sex is clearly a significant risk factor, human leukocyte antigen status is probably important but further studies are needed, abnormalities in alcohol metabolism have not been shown to be of primary pathogenic importance and the plethora of immunological disturbances reported appear to be mere epiphenomena. Of the environmental factors, no consistent evidence attests to the significance of hepatitis B viral infection in the susceptibility to developing alcoholic liver disease.
Johnson RD, Williams R; Alcohol 20 (2): 137-60 (1985)
Maternal Medication usually Compatible with Breast-Feeding: alcohol (ethanol): Reported Sign or Symptom in Infant or Effect on Lactation: With large amounts drowsiness, diaphoresis, deep sleep, weakness, decrease in linear growth, abnormal weight gain; maternal ingestion of 1 g/kg daily decreases milk ejection reflex. /from Table 6/
Report of the American Academy of Pediatrics Committee on Drugs in Pediatrics 93 (1): 140 (1994)
Two weeks after percutaneous ethanol injection therapy for hepatocellular carcinoma, performed by injecting 110 mL ethanol in a single session with general anesthesia, a 69-year-old woman with well-compensated liver cirrhosis developed an extensive thrombosis of the whole portal tree that caused severe uncorrectable ascites and progressive deterioration of her general condition, resulting in death 6 weeks after the procedure.
PMID:9922194 Lencioni R et al; Abdom Imaging 23 (6): 608-10 (1998)
Two patients developed hepatic infarction after undergoing percutaneous ethanol injection therapy (PEIT) for hepatocellular carcinoma (HCC). In both cases, liver function parameters deteriorated immediately after the ethanol injection, and enhanced computed tomography images showed a wedge-shaped avascular low-density area due to hepatic infarction. In one patient, PEIT was performed for a nodule treated with transcatheter arterial infusion (TAI) using a suspension of styrene maleic acid neocarzinostatin (SMANCS) 4 weeks before. In the other patient, TAI with SMANCS had been carried out 14 months previously for a different nodule in the same segment where the nodule treated with PEIT was located. When PEIT is used for patients with HCC who have previously undergone TAI, especially with SMANCS, PEIT may induce hepatic infarction.
PMID:9872612 Seki T et al; Eur J Gastroenterol Hepatol 10 (11): 915-8
Since 1990, percutaneous ethanol injection therapy (PEIT) has been clinically applied as a treatment for autonomous functioning nodules of the thyroid as well as for cystic lesions. Some additional indications are currently under consideration, e.g. inoperable advanced cancer of the thyroid. Since its inception, PEIT has generally been regarded as an effective, low-risk, inexpensive procedure which can be performed on an ambulatory basis. /The authors/ report the first case of severe ethyl toxic necrosis of the larynx combined with necrotic dermatitis in a patient treated with PEIT by a radiologist. The patient was admitted to hospital, where the necrosis and dermatitis were treated conservatively. A cyst which developed in the right false vocal fold was removed by microsurgery 10 months later. Voice was restored almost to normal but a significant reduction in nodular volume was not seen, probably due to the inexperience of the operator. PEIT for functional thyroid gland autonomy is an inexpensive method of treating hyperthyroidism with focal autonomy on an ambulatory basis if surgical intervention and radioiodine therapy are not feasible either for medical reasons or because of refusal by the patient. Severe complications must be taken into consideration and discussed with the patient. To avoid complications, substantial experience and a precise ultrasound-guided injection are required. In the case of complications the opinion of a specialist should be sought at an early stage.
PMID:15768823 Mauz PS et al; Acta Otolaryngol 124 (10): 1226-30 (2004)
... The fatal dose of ethanol is between 500 and 1000 mL of 100-proof liquor (50% ethanol), ingested in an hour or two. ...
PMID:4574410 McBay AJ; Clinical Chemistry 19 (4): 361-365 (1973)
For therapeutic neurolysis of nerves or ganglia for the relief of intractable chronic pain in such conditions as inoperable cancer and trigeminal neuralgia (tic douloureux), in patients for whom neurosurgical procedures are contraindicated.
Treatment of congenital venous malformations
Treatment of uncontrolled primary hypertension
Alcohol produces injury to cells by dehydration and precipitation of the cytoplasm or protoplasm. This accounts for its bacteriocidal and antifungal action. When alcohol is injected in close proximity to nerve tissues, it produces neuritis and nerve degeneration (neurolysis). Ninety to 98% of ethanol that enters the body is completely oxidized. Ethanol is also used as a cosolvent to dissolve many insoluble drugs and to serve as a mild sedative in some medicinal formulations. Ethanol also binds to GABA, glycine, NMDA receptors and modulates their effects. Ethanol is also metabolised by the hepatic enzyme alcohol dehydrogenase.
Anti-Infective Agents, Local
Substances used on humans and other animals that destroy harmful microorganisms or inhibit their activity. They are distinguished from DISINFECTANTS, which are used on inanimate objects. (See all compounds classified as Anti-Infective Agents, Local.)
Central Nervous System Depressants
A very loosely defined group of drugs that tend to reduce the activity of the central nervous system. The major groups included here are ethyl alcohol, anesthetics, hypnotics and sedatives, narcotics, and tranquilizing agents (antipsychotics and antianxiety agents). (See all compounds classified as Central Nervous System Depressants.)
Solvents
Liquids that dissolve other substances (solutes), generally solids, without any change in chemical composition, as, water containing sugar. (Grant and Hackh's Chemical Dictionary, 5th ed) (See all compounds classified as Solvents.)
D08AX08
S76 | LUXPHARMA | Pharmaceuticals Marketed in Luxembourg | Pharmaceuticals marketed in Luxembourg, as published by d'Gesondheetskeess (CNS, la caisse nationale de sante, www.cns.lu), mapped by name to structures using CompTox by R. Singh et al. (in prep.). List downloaded from https://cns.public.lu/en/legislations/textes-coordonnes/liste-med-comm.html. Dataset DOI:10.5281/zenodo.4587355
D - Dermatologicals
D08 - Antiseptics and disinfectants
D08A - Antiseptics and disinfectants
D08AX - Other antiseptics and disinfectants
D08AX08 - Ethanol
V - Various
V03 - All other therapeutic products
V03A - All other therapeutic products
V03AB - Antidotes
V03AB16 - Ethanol
V - Various
V03 - All other therapeutic products
V03A - All other therapeutic products
V03AZ - Nerve depressants
V03AZ01 - Ethanol
Absorption
Rapidly absorbed.
After oral administration, ethanol is absorbed rapidly into the bloodstream from the stomach and small intestines and distributes into total body water (0.5-0.7 L/kg). Peak blood levels occur about 30 minutes after ingestion of ethanol when the stomach is empty. Because absorption occurs more rapidly from the small intestine than from the stomach, delays in gastric emptying (owing, e.g., to the presence of food) slow ethanol absorption. ... After oral consumption of alcohol, first-pass metabolism by gastric and liver alcohol dehydrogenase enzymes leads to lower blood alcohol levels than would be obtained if the same dose were administered intravenously.
Brunton, L. Chabner, B, Knollman, B. Goodman and Gillman's The Pharmaceutical Basis of Therapeutics, Twelth Edition, McGraw Hill Medical, New York, NY. 2011, p. 630
The distribution of alcohol between alveolar air and blood depends on its speed of diffusion, and its vapor pressure at the prevailing temp and concentration of alcohol in the lung capillaries. Empirical determinations have yielded rather different values for this distribution ratio, but a commonly accepted value is 1:2100.
International Encyclopedia of Pharmacology and Therapeutics. Vol 1 Section 20: 170 (1970)
Venous blood (orbital sinus) and brain ethanol levels were measured in long sleep and short sleep mice within the first 30 min following ethanol administration (2.5 to 6.0 g/kg). Ethanol was administered ip or intragastrically. For both lines of mice and for every dose, brain ethanol concentrations were significantly greater (as much as 100 mg/dL) than blood ethanol levels for the first 6 min, and peak blood and brain ethanol levels were reached 4 to 6 min after dosing. Approx 6 to 10 min (depending on dose and line of mouse) was required for blood and brain concn to reach equilibrium. At the time of loss of the righting response brain ethanol levels were significantly higher than blood ethanol levels. These results indicate that within the first 6 min after administration of ethanol, blood ethanol level is not suitable for the assessment of brain ethanol content.
PMID:2719816 Smolen TN, Smolen A; Alcohol 6 (1): 33-8 (1989)
The method of Pohorecky and Brick was modified for determination of ethanol concn in rebreathed air of rats. Female Sprague Dawley rats were injected with different doses (1 to 2 g/kg) of ethanol and both arterial blood and rebreathed air samples were collected at various time intervals (15 to 120 min) after administration. A good correlation (r= 0.96) was found between ethanol concn in arterial blood and in rebreathed air; the blood/breath conversion factor was 3241 + or - 55.
PMID:2719817 Hiltunen AJ et al; Alcohol 6 (1): 39-43 (1989)
For more Absorption, Distribution and Excretion (Complete) data for Ethanol (31 total), please visit the HSDB record page.
Hepatic. Metabolized by cytochrome P450 enzyme CYP2E1.
Ethanol metabolism in hepatocytes causes the generation of reactive oxygen species, endoplasmic reticulum stress and alterations in mitochondrial energy and REDOX metabolism. In ethanol-exposed liver disease, autophagy not only acts as a cleanser to remove damaged organelles and cytosolic components, but also selectively clears specific targets such as lipid droplets and damaged mitochondria. Moreover, ethanol appears to play a role in protecting hepatocytes from apoptosis at certain concentrations. This article describes the evidence, function and potential mechanism of autophagy in ethanol-exposed liver disease and the controversy surrounding the effects of ethanol on autophagy.
PMID:26186640 Wang LR et al; Expert Rev Gastroenterol Hepatol 9 (8): 1031-7 (2015)
There have been allegations in the courtroom that elevated serum lactic acid in trauma victims can yield a falsely elevated serum ethanol assay. Most hospitals utilize an indirect method of ethanol measurement where a serum sample is added to a mix of alcohol dehydrogenase and oxidized nicotinamide adenine dinucleotide (NAD+). This allows any ethanol in the patient's serum to be metabolized to acetaldehyde, and in the process results in the reduction of NAD+ to NADH. NADH is then measured using spectrophotometry. The courtroom allegation stems from the concept that oxidation of lactate to pyruvate by lactate dehydrogenase (LDH) results in the same molar-for-molar reduction of NAD+ to NADH, and could therefore theoretically cause patients with elevated lactate and LDH to have a falsely elevated ethanol concentration. Patients with elevated lactic acid and LDH concentrations who presented to a university hospital from 20 April 2015 to 13 December 2015 were identified to provide possible test specimens. If a sufficient amount of serum was available, the sample was used to re-run the lactate and LDH concentration simultaneously with an enzymatic ethanol assay. Any samples that had elevated lactic acid and LDH concentrations on this retesting, and also yielded a positive ethanol concentration, were sent for confirmatory gas chromatography testing of ethanol concentrations. A control group of 20 samples with normal lactate and LDH were included. A total of 37 samples were included in the final analysis. Only 4 patients had an elevated enzymatic ethanol concentration, and all 4 also had a measurable GC ethanol concentration. The lactate in this dataset ranged from 2.4 to 24.2 mmol/L, with a mean of 6.53 mmol/L (normal value 0.5-2.2). The LDH ranged from 242 to 8838 U/L with a mean of 1695 U/L (normal value 122-225 U/L). Twenty control samples were run on patients with normal lactate and LDH, none of which yielded a positive enzymatic ethanol result. This data does not support the contention that an elevated LDH and lactate can yield a false positive serum ethanol result as run by enzymatic ethanol assay in live patients presenting to the emergency department.
PMID:28812382 Nacca N et al; Clin Toxicol (Phila) 16: 1-4 (2017)
Ethanol is metabolized largely by sequential hepatic oxidation, first to acetaldehyde by alcohol dehydrogenase (ADE) and then to acetic acid by aldehyde dehydrogenase (ALDH). Each metabolic step requires NAD+; thus oxidation of 1 mol ethanol (46 g) to 1 mol acetic acid requires 2 mol NAD+ in the liver; indeed, NAD+ availability limits ethanol metabolism to about 8 gr or 10 mL (approximately 170 mmol) per hour in a 70-kg adult, or approximately 120 mg/kg per hour. Thus hepatic ethanol metabolism functionally saturates at relatively low blood levels compared with the high blood ethano levels (BELs) achieved, and ethanol metabolism is a zero-order process (constant amount per unit time). Small amounts of ethanol are excreted in urine, sweat, and breath, but metabolism to acetate accounts to 90-98% of ingested ethanol, mostly owing to hepatic metabolism by ADH and ADLH.
Brunton, L. Chabner, B, Knollman, B. Goodman and Gillman's The Pharmaceutical Basis of Therapeutics, Twelth Edition, McGraw Hill Medical, New York, NY. 2011, p. 630
Metabolism of ethanol, propanol, isopropanol, butanol, isobutanol, sec-butanol, and tert-butanol was studied after oral administration in rabbits. Blood pH was on the acid side with propanol, butanol, and isobutanol, and on the alkaline side with isopropanol and sec-butanol, but no change was observed with ethanol and tert-butanol. Butanol and isobutanol had the lowest rate of urinary excretion. Acetaldehyde and acetic acid were detected as the urinary metabolites of ethanol and propanol, whereas isobutyraldehyde and isovaleric acid were the metabolites of isobutanol.
Saito M; Nichidai Igaku Zasshi 34 (8-9): 569-85 (1975)
For more Metabolism/Metabolites (Complete) data for Ethanol (13 total), please visit the HSDB record page.
Ethanol has known human metabolites that include acetaldehyde.
S73 | METXBIODB | Metabolite Reaction Database from BioTransformer | DOI:10.5281/zenodo.4056560
... The concentrations of ethanol and methanol in blood were determined indirectly by analysis of end-expired alveolar air. In the morning when blood-ethanol dropped below the Km of liver alcohol dehydrogenase (ADH) of about 100 mg/L (2.2 mM), the disappearance half-life of ethanol was 21, 22, 18 and 15 min. in 4 test subjects respectively. ...
PMID:3588516 Jones AW; Pharmacol Toxicol. 60 (3): 217-20 (1987)
Ethanol affects the brains neurons in several ways. It alters their membranes as well as their ion channels, enzymes, and receptors. Alcohol also binds directly to the receptors for acetylcholine, serotonin, GABA, and the NMDA receptors for glutamate. The sedative effects of ethanol are mediated through binding to GABA receptors and glycine receptors (alpha 1 and alpha 2 subunits). It also inhibits NMDA receptor functioning. In its role as an anti-infective, ethanol acts as an osmolyte or dehydrating agent that disrupts the osmotic balance across cell membranes.
... Ethanol is known to affect a large number of membrane proteins that participate in signaling pathways such as neurotransmitter receptors, enzymes, and ion channels, and there is extensive evidence that ethanol interacts with a variety of neurotransmitters. The major actions of ethanol involve enhancing the inhibitory effects of gamma-aminobutyric acid (GABA) at GABAa receptors and blockade of the N-methyl-D-aspartate (NMDA) subtype of glutamate, an excitatory amine acid (EAA) receptor. Animal studies indicate that the acute effects of ethanol result from competitive inhibition of glycine binding to NMDA receptor and disruption of glutamatergic neurotransmission by inhibiting the response of the NMDA receptor. Persistent glycine antagonism and attenuation of glutamatergic neurotransmission by chronic ethanol exposure results in tolerance to ethanol by enhancing EAA neurotransmission and NMDA receptor upregulation. The latter appears to involve selective increases in NMDA R2B subunit concentrations and other molecular changes in specific brain loci. The abrupt withdrawal of ethanol thus produces a hyperexcitable state that leads to the ethanol withdrawal syndrome and excitotoxic neuronal death. GABA-mediated inhibition, which normally acts to limit excitation, is eliminated during ethanol withdrawal syndrome and further intensifies this excitation. In addition, NMDA receptors function to inhibit the release of dopamine in the nucleus accumbens and mesolimbic structures, which modulate the reinforcing action of addictive xenobiotics such as ethanol. By inhibiting NMDA receptor activity, ethanol could increase dopamine release from the nucleus accumbens and ventral tegmental area and could thus create dependence. Chronic ethanol administration also results in tolerance, dependence, and an ethanol withdrawal syndrome, mediated, in part, by desensitization and or downregulation of GABAa receptors.
Goldfrank, L.R., Goldfrank's Toxicologic Emergencies 10th Ed. 2015., McGraw-Hill, New York, N.Y., p. 1085
The development of alcoholic ketoacidosis (AKA) requires that a combination of physical and physiologic events occur. The normal response to starvation and depletion of hepatic glycogen stores is for amino acids to be converted to pyruvate. Pyruvate can serve as a substrate for gluconeogenesis, be converted to acetyl-CoA, which can enter the Krebs cycle or can be utilized in various biosynthetic pathways (eg, fatty acid, ketone bodies, cholesterol, and acetylcholine) ... Ethanol metabolism generates NADH, resulting in an excess of reducing potential. This high redox state favors the conversion of pyruvate to lactate, diverting pyruvate from being a substrate for gluconeogenesis. To compensate for the lack of normal metabolic substrates, the body mobilizes fat from adipose tissue and increased fatty acid metabolism as an alternative source of energy. This response is mediated by a decrease in insulin and an increased secretion of glucagon, catecholamines, growth hormone, and cortisol. Fatty acid metabolism results in the formation of acetyl-CoA and it combines with the excess acetate that is generated from ethanol metabolism to form acetoacetate. Most of the acetoacetate is reduced to beta-hydroxybutyrate due to the excess reducing potential or high redox state of the cell. Volume depletion interferes with the renal elimination of acetoacetate and beta-hydroxybutyrate, and contributes to the acidosis. An elevated lactate concentration may result from shunting from pyruvate or from hypoperfusion or infection that may coexist with the underlying ketoacidosis.
Goldfrank, L.R., Goldfrank's Toxicologic Emergencies 10th Ed. 2015., McGraw-Hill, New York, N.Y., p. 1088
Adenosine may mediate many of the acute and chronic motor effects of ethanol on the brain. Ethanol, probably through its metabolite, acetate, prevents adenosine uptake, raising synaptic adenosine concentrations. Excessive stimulation of several adenosine receptors in the cerebellum may explain much of the motor impairment from low ethanol concentrations. In fact, animals made tolerant to ethanol develop cross-tolerance to adenosine agonists. In mice, adenosine receptor agonists increase ethanol-induced incoordination while adenosine antagonists decrease this intoxicating response.
Goldfrank, L.R. (ed). Goldfrank's Toxicologic Emergencies. 7th Edition McGraw-Hill New York, New York 2002., p. 162
Chronic ethanol (alcohol) administration has been associated with alterations in the binding and function of the gamma-aminobutyric acid (GABAA) receptor. To evaluate the mechanism underlying these changes, /the authors/ measured the steady state levels of the mRNAs for the alpha 1, alpha 2, alpha 3, alpha 5, and alpha 6 subunits of the GABAA receptor after chronic ethanol administration to rats and ethanol withdrawal for 24 hr. The results indicated that chronic ethanol administration resulted in a 61% decline in the level of the GABAA receptor alpha 1 subunit mRNAs [3.8 and 4.3 kilobases (kb)] in the cerebral cortex in rats. The levels of the alpha 2 subunit mRNAs (6 and 3 kb) and the alpha 5 subunit mRNA (2.8 kb) were also reduced, by 61, 45, and 51%, respectively, whereas there was no change in the level of the alpha 3 subunit mRNA (3 kb). Furthermore, the ethanol-induced decrease in receptor mRNA levels persisted for 24 hr, after withdrawal of ethanol and returned to control values at 36 hr of withdrawal. alpha 1 mRNA levels in cerebellum also decreased by 28%. The level of the alpha 6 subunit mRNA, which selectively encodes Ro15-4513 binding sites, was found to be increased by approximately 76% in the cerebellum. Also, the photoaffinity labeling studies using [3H]Ro15-4513 indicated an increase in the levels of various protein components of the GABAA receptor, in the cerebellum and the cerebral cortex (e.g., 50- and 55-kDa proteins in the cerebellum and 41- and 50-kDa proteins in the cortex), after chronic ethanol treatment. The increase in alpha 6 mRNA in the cerebellum might be related to the increased labeling of the 55-kDa (approximately 56-kDa) protein and partially responsible for the increased binding ... . Because the alpha 6 subunit is not expressed in cortex, involvement of an as yet unknown subunit in this region cannot be ruled out. The effect of chronic ethanol treatment appears to be specific for GABAA receptor subunit mRNAs, because the same treatment did not alter the levels of glyceraldehyde-3-dehydrogenase mRNA or poly(A)+ RNA. In summary, these data indicate that chronic ethanol treatment results in an alteration in the regulation of expression of GABAA receptor subunit-encoding mRNAs, which could be due to alterations in transcription or mRNA stability.
PMID:1383684 Mhatre MC et al; Mol Pharmacol 42 (3): 415-22 (1992)
For more Mechanism of Action (Complete) data for Ethanol (8 total), please visit the HSDB record page.
GDUFA
DMF Review : N/A
Rev. Date :
Pay. Date :
DMF Number : 10498
Submission : 1993-09-28
Status : Active
Type : II

GDUFA
DMF Review : Reviewed
Rev. Date : 2022-04-07
Pay. Date : 2022-04-04
DMF Number : 31348
Submission : 2017-01-31
Status : Active
Type : II

GDUFA
DMF Review : N/A
Rev. Date :
Pay. Date :
DMF Number : 32513
Submission : 2018-02-06
Status : Active
Type : II

GDUFA
DMF Review : N/A
Rev. Date :
Pay. Date :
DMF Number : 39201
Submission : 2023-11-24
Status : Active
Type : IV

GDUFA
DMF Review : N/A
Rev. Date :
Pay. Date :
DMF Number : 39202
Submission : 2023-11-24
Status : Active
Type : IV

GDUFA
DMF Review : N/A
Rev. Date :
Pay. Date :
DMF Number : 31237
Submission : 2016-12-21
Status : Inactive
Type : IV

GDUFA
DMF Review : N/A
Rev. Date :
Pay. Date :
DMF Number : 31681
Submission : 2017-03-30
Status : Inactive
Type : II

GDUFA
DMF Review : N/A
Rev. Date :
Pay. Date :
DMF Number : 5039
Submission : 1983-07-26
Status : Inactive
Type : II

GDUFA
DMF Review : N/A
Rev. Date :
Pay. Date :
DMF Number : 15095
Submission : 2000-10-09
Status : Inactive
Type : II

GDUFA
DMF Review : N/A
Rev. Date :
Pay. Date :
DMF Number : 36476
Submission : 2022-03-22
Status : Inactive
Type : II

FULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]
GDUFA
DMF Review : N/A
Rev. Date :
Pay. Date :
DMF Number : 3107
Submission : 1977-12-27
Status : Inactive
Type : II

GDUFA
DMF Review : N/A
Rev. Date :
Pay. Date :
DMF Number : 15095
Submission : 2000-10-09
Status : Inactive
Type : II

GDUFA
DMF Review : N/A
Rev. Date :
Pay. Date :
DMF Number : 31237
Submission : 2016-12-21
Status : Inactive
Type : IV

GDUFA
DMF Review : N/A
Rev. Date :
Pay. Date :
DMF Number : 31042
Submission : 2016-10-20
Status : Active
Type : II

GDUFA
DMF Review : N/A
Rev. Date :
Pay. Date :
DMF Number : 10498
Submission : 1993-09-28
Status : Active
Type : II

GDUFA
DMF Review : N/A
Rev. Date :
Pay. Date :
DMF Number : 8191
Submission : 1989-08-10
Status : Inactive
Type : II

GDUFA
DMF Review : N/A
Rev. Date :
Pay. Date :
DMF Number : 5039
Submission : 1983-07-26
Status : Inactive
Type : II

GDUFA
DMF Review : Complete
Rev. Date : 2022-04-07
Pay. Date : 2022-04-04
DMF Number : 31348
Submission : 2017-01-31
Status : Active
Type : II

GDUFA
DMF Review : N/A
Rev. Date :
Pay. Date :
DMF Number : 26756
Submission : 2013-01-30
Status : Active
Type : II

FULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]
Boost your online visibility by uploading your products, APIs, FDFs, intermediates, excipients, and services for free on PharmaCompass.
Rank higher among suppliers and expand your reach across the internet efficiently and cost-effectively.

Wool Alcohols, Product Codes: LD04817, LD06105, ...
Certificate Number : R1-CEP 2001-382 - Rev 01
Status : Valid
Issue Date : 2015-10-20
Type : TSE
Substance Number : 593

Boost your online visibility by uploading your products, APIs, FDFs, intermediates, excipients, and services for free on PharmaCompass.
Rank higher among suppliers and expand your reach across the internet efficiently and cost-effectively.

Wool Alcohols, Product Codes: LD02643, LD04888, ...
Certificate Number : R1-CEP 2001-368 - Rev 00
Status : Valid
Issue Date : 2007-07-18
Type : TSE
Substance Number : 593

Boost your online visibility by uploading your products, APIs, FDFs, intermediates, excipients, and services for free on PharmaCompass.
Rank higher among suppliers and expand your reach across the internet efficiently and cost-effectively.

Certificate Number : R1-CEP 2014-082 - Rev 00
Status : Valid
Issue Date : 2020-01-23
Type : Chemical
Substance Number : 1317

Boost your online visibility by uploading your products, APIs, FDFs, intermediates, excipients, and services for free on PharmaCompass.
Rank higher among suppliers and expand your reach across the internet efficiently and cost-effectively.

Wool Alcohols, (Product Codes: LD08421, LD08107,...
Certificate Number : R0-CEP 2001-312 - Rev 01
Status : Expired
Issue Date : 2005-03-22
Type : TSE
Substance Number : 593

Boost your online visibility by uploading your products, APIs, FDFs, intermediates, excipients, and services for free on PharmaCompass.
Rank higher among suppliers and expand your reach across the internet efficiently and cost-effectively.

Certificate Number : CEP 2023-407 - Rev 00
Status : Valid
Issue Date : 2024-11-04
Type : TSE
Substance Number : 593

Boost your online visibility by uploading your products, APIs, FDFs, intermediates, excipients, and services for free on PharmaCompass.
Rank higher among suppliers and expand your reach across the internet efficiently and cost-effectively.

Certificate Number : CEP 2011-300 - Rev 01
Status : Withdrawn by Holder
Issue Date : 2023-12-11
Type : TSE
Substance Number : 593

FULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results] 5% nitroglycerin ethanol solution
Registration Number : 218MF10624
Registrant's Address : Kalkstrasse 218, 51377 Leverkusen, Germany
Initial Date of Registration : 2006-07-20
Latest Date of Registration : 2020-12-15

40% Mandelnitrile Ethanol Solution
Registration Number : 218MF10694
Registrant's Address : 2-1-5 Doshomachi, Chuo-ku, Osaka City, Osaka Prefecture
Initial Date of Registration : 2006-08-11
Latest Date of Registration : 2006-08-11

FULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]Artemisia leaf 95% ethanol soft extract (20→1)
Registrant Name : Dasan Pharmaceutical Co., Ltd.
Registration Date : 2021-04-12
Registration Number : 20210310-9-K-64-08(1)
Manufacturer Name : Guangdong Qingyunshan Pharma...
Manufacturer Address : No.369, Huanchengbei Road, Longxian Town, Wengyuan Country, Guangdong Province, China

Artemisia leaf 95% ethanol soft extract (20→1)
Registrant Name : Otran Korea Co., Ltd.
Registration Date : 2021-03-10
Registration Number : 20210310-9-K-64-08
Manufacturer Name : Guangdong Qingyunshan Pharma...
Manufacturer Address : No.369, Huanchengbei Road, Longxian Town, Wengyuan County, Guangdong Province, China

Artemisia leaf 95% ethanol soft extract (20→1)
Registrant Name : Gukjeon Co., Ltd.
Registration Date : 2021-01-27
Registration Number : 20210127-9-K-61-07
Manufacturer Name : Zhejiang Huisong Pharmaceuti...
Manufacturer Address : FarFavour Pharmaceuticals Healthcare Industrial Park, Heping Changxing, Zhejiang, Chi...

30% ethanol dry extract of Weilingxian, Gualu root, and Hagochao (40→1)
Registrant Name : Gukjeon Co., Ltd.
Registration Date : 2023-07-19
Registration Number : 20230719-8-K-78-05
Manufacturer Name : Zhejiang Huisong Pharmaceuti...
Manufacturer Address : FarFavour Pharmaceuticals Healthcare Industrial Park, Heping Changxing, Zhejiang, Chi...

Artemisia leaf 95% ethanol soft extract (20→1))
Registrant Name : Dong-A ST Co., Ltd.
Registration Date : 2021-07-06
Registration Number : 20210706-9-K-65-09
Manufacturer Name : Hunan Jiudian Pharmaceutical...
Manufacturer Address : Hunan Liuyang Bio-pharmaceutical Industrial Park, Changsha, Hunan, 410329, PR, China

Magnolia bark 75% ethanol soft extract (5→1)
Registrant Name : Hiple Co., Ltd.
Registration Date : 2022-10-26
Registration Number : 20220517-211-J-1295(1)
Manufacturer Name : Hunan Tianlong Pharmaceutica...
Manufacturer Address : No. 228, Wangcheng Avenue, Wangcheng Economic and Technological Development Zone, Cha...

Magnolia bark 75% ethanol soft extract (5:1)
Registrant Name : Ester Corporation Co., Ltd.
Registration Date : 2022-05-17
Registration Number : 20220517-211-J-1295
Manufacturer Name : Hunan Tianlong Pharmaceutica...
Manufacturer Address : No. 228, Wangcheng Avenue, Wangcheng Econonic and Technological Development Zone, Cha...

30% ethanol dry extract of Weilingxian, Gualu root, and Hagochao (40→1)
Registrant Name : Otran Pharm Korea Co., Ltd.
Registration Date : 2021-09-03
Registration Number : 20210903-8-K-66-03
Manufacturer Name : Hunan Warrant Pharmaceutical...
Manufacturer Address : Jiankang South Road No.5, Liuyang Biomedical Park, Hunan Province, China

Artemisia leaf 95% ethanol soft extract (20→1)
Registrant Name : Hyundai Bioland Co., Ltd.
Registration Date : 2017-12-28
Registration Number : 20171228-9-K-23-03
Manufacturer Name : Hyundai Bioland Co., Ltd.
Manufacturer Address : 22, Osongsaengmyeong 2-ro, Osong-eup, Heungdeok-gu, Cheongju-si, Chungcheongbuk-do

30% ethanol dry extract of Weilingxian, Gualu root, and Hagochao (40→1)
Registrant Name : Poonglim Pharmaceutical Co., Ltd.
Registration Date : 2022-09-19
Registration Number : 20220919-8-K-74-04
Manufacturer Name : Ningbo Green-Health Pharmace...
Manufacturer Address : Xiwu Town Foreign Technological Garden, Fenghua District, Ningbo, Zhejiang, China

FULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]About the Company : Brenntag is the global market leader in providing a full range of chemicals and ingredients and value-added services. By connecting chemical manufacturers (our suppliers) and chemi...

About the Company : Harman Finochem Limited is a leading India-based Pharmaceutical Company which specializes in the manufacture and export of more than 45 Active Pharmaceutical Ingredients (APls) of ...

About the Company : ReAgent is a Leading UK Chemical Supplier. We specialise in services such as Chemical Blending, Contract Packing, Contract Manufacturing, Sachet Filling and more. We are based in C...

FULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]
Boost your online visibility by uploading your products, APIs, FDFs, intermediates, excipients, and services for free on PharmaCompass.
Rank higher among suppliers and expand your reach across the internet efficiently and cost-effectively.
Details:
Ablysinol-Generic is an ablative agent indicated to induce controlled cardiac septal infarction to improve exercise capacity in adults with symptomatic hypertrophic obstructive cardiomyopathy.
Lead Product(s): Ethanol,Inapplicable
Therapeutic Area: Cardiology/Vascular Diseases Brand Name: Ablysinol-Generic
Study Phase: Approved FDFProduct Type: Miscellaneous
Sponsor: Undisclosed
Deal Size: Inapplicable Upfront Cash: Inapplicable
Deal Type: Inapplicable June 24, 2025
Boost your online visibility by uploading your products, APIs, FDFs, intermediates, excipients, and services for free on PharmaCompass.
Rank higher among suppliers and expand your reach across the internet efficiently and cost-effectively.
Lead Product(s) : Ethanol,Inapplicable
Therapeutic Area : Cardiology/Vascular Diseases
Highest Development Status : Approved FDF
Partner/Sponsor/Collaborator : Undisclosed
Deal Size : Inapplicable
Deal Type : Inapplicable
Breckenridge Gets FDA Nod For Dehydrated Alcohol Injection, Ablysinol Generic
Details : Ablysinol-Generic is an ablative agent indicated to induce controlled cardiac septal infarction to improve exercise capacity in adults with symptomatic hypertrophic obstructive cardiomyopathy.
Product Name : Ablysinol-Generic
Product Type : Miscellaneous
Upfront Cash : Inapplicable
June 24, 2025
Boost your online visibility by uploading your products, APIs, FDFs, intermediates, excipients, and services for free on PharmaCompass.
Rank higher among suppliers and expand your reach across the internet efficiently and cost-effectively.
Details:
Hezkue Sildenafil (Sildenafil) is a small molecule drug candidate, which is currently being evaluated in Phase II clinical studies for the treatment of Erectile Dysfunction.
Lead Product(s): Sildenafil Citrate,Ethanol
Therapeutic Area: Psychiatry/Psychology Brand Name: Hezkue Sildenafil
Study Phase: Phase IIProduct Type: Miscellaneous
Sponsor: Undisclosed
Deal Size: Inapplicable Upfront Cash: Inapplicable
Deal Type: Inapplicable December 18, 2025

Boost your online visibility by uploading your products, APIs, FDFs, intermediates, excipients, and services for free on PharmaCompass.
Rank higher among suppliers and expand your reach across the internet efficiently and cost-effectively.
Lead Product(s) : Sildenafil Citrate,Ethanol
Therapeutic Area : Psychiatry/Psychology
Highest Development Status : Phase II
Partner/Sponsor/Collaborator : Undisclosed
Deal Size : Inapplicable
Deal Type : Inapplicable
Effect of Moderate Alcohol on Absorption and Onset of Hezkue Sildenafil Suspension
Details : Hezkue Sildenafil (Sildenafil) is a small molecule drug candidate, which is currently being evaluated in Phase II clinical studies for the treatment of Erectile Dysfunction.
Product Name : Hezkue Sildenafil
Product Type : Miscellaneous
Upfront Cash : Inapplicable
December 18, 2025

Boost your online visibility by uploading your products, APIs, FDFs, intermediates, excipients, and services for free on PharmaCompass.
Rank higher among suppliers and expand your reach across the internet efficiently and cost-effectively.
Details:
Alcohol is a Other Small Molecule drug candidate, which is currently being evaluated in Phase III clinical studies for the treatment of Hypertension.
Lead Product(s): Ethanol,Inapplicable
Therapeutic Area: Cardiology/Vascular Diseases Brand Name: Undisclosed
Study Phase: Phase IIIProduct Type: Miscellaneous
Sponsor: Undisclosed
Deal Size: Inapplicable Upfront Cash: Inapplicable
Deal Type: Inapplicable July 24, 2025

Boost your online visibility by uploading your products, APIs, FDFs, intermediates, excipients, and services for free on PharmaCompass.
Rank higher among suppliers and expand your reach across the internet efficiently and cost-effectively.
Lead Product(s) : Ethanol,Inapplicable
Therapeutic Area : Cardiology/Vascular Diseases
Highest Development Status : Phase III
Partner/Sponsor/Collaborator : Undisclosed
Deal Size : Inapplicable
Deal Type : Inapplicable
Renal Artery Denervation Assessment Without Antihypertensive Medication Regimen (RADAR)
Details : Alcohol is a Other Small Molecule drug candidate, which is currently being evaluated in Phase III clinical studies for the treatment of Hypertension.
Product Name : Undisclosed
Product Type : Miscellaneous
Upfront Cash : Inapplicable
July 24, 2025

Boost your online visibility by uploading your products, APIs, FDFs, intermediates, excipients, and services for free on PharmaCompass.
Rank higher among suppliers and expand your reach across the internet efficiently and cost-effectively.
Details:
Ablysinol-Generic is an ablative agent indicated to induce controlled cardiac septal infarction to improve exercise capacity in adults with symptomatic hypertrophic obstructive cardiomyopathy.
Lead Product(s): Ethanol,Inapplicable
Therapeutic Area: Cardiology/Vascular Diseases Brand Name: Ablysinol-Generic
Study Phase: Approved FDFProduct Type: Miscellaneous
Sponsor: Undisclosed
Deal Size: Inapplicable Upfront Cash: Inapplicable
Deal Type: Inapplicable July 21, 2025

Boost your online visibility by uploading your products, APIs, FDFs, intermediates, excipients, and services for free on PharmaCompass.
Rank higher among suppliers and expand your reach across the internet efficiently and cost-effectively.
Lead Product(s) : Ethanol,Inapplicable
Therapeutic Area : Cardiology/Vascular Diseases
Highest Development Status : Approved FDF
Partner/Sponsor/Collaborator : Undisclosed
Deal Size : Inapplicable
Deal Type : Inapplicable
Avenacy Announces Launch of Dehydrated Alcohol Injection, USP Vials in the U.S. Market
Details : Ablysinol-Generic is an ablative agent indicated to induce controlled cardiac septal infarction to improve exercise capacity in adults with symptomatic hypertrophic obstructive cardiomyopathy.
Product Name : Ablysinol-Generic
Product Type : Miscellaneous
Upfront Cash : Inapplicable
July 21, 2025

Boost your online visibility by uploading your products, APIs, FDFs, intermediates, excipients, and services for free on PharmaCompass.
Rank higher among suppliers and expand your reach across the internet efficiently and cost-effectively.
Details:
Dehydrated Alcohol is approved by FDA and is indicated to induce controlled cardiac septal infarction to improve exercise capacity in adults with symptomatic hypertrophic obstructive cardiomyopathy.
Lead Product(s): Ethanol,Inapplicable
Therapeutic Area: Cardiology/Vascular Diseases Brand Name: Ablysinol-Generic
Study Phase: Approved FDFProduct Type: Miscellaneous
Sponsor: Undisclosed
Deal Size: Inapplicable Upfront Cash: Inapplicable
Deal Type: Inapplicable June 25, 2025

Boost your online visibility by uploading your products, APIs, FDFs, intermediates, excipients, and services for free on PharmaCompass.
Rank higher among suppliers and expand your reach across the internet efficiently and cost-effectively.
Lead Product(s) : Ethanol,Inapplicable
Therapeutic Area : Cardiology/Vascular Diseases
Highest Development Status : Approved FDF
Partner/Sponsor/Collaborator : Undisclosed
Deal Size : Inapplicable
Deal Type : Inapplicable
Accord Healthcare Launches Dehydrated Alcohol Injection for Cardiovascular Indications
Details : Dehydrated Alcohol is approved by FDA and is indicated to induce controlled cardiac septal infarction to improve exercise capacity in adults with symptomatic hypertrophic obstructive cardiomyopathy.
Product Name : Ablysinol-Generic
Product Type : Miscellaneous
Upfront Cash : Inapplicable
June 25, 2025

Details:
AFA-281 is a drug candidate, which is currently being evaluated in phase I clinical studies for the treatment of Alcoholism.
Lead Product(s): AFA-281,Ethanol
Therapeutic Area: Psychiatry/Psychology Brand Name: Undisclosed
Study Phase: Phase IProduct Type: Undisclosed
Sponsor: Undisclosed
Deal Size: Inapplicable Upfront Cash: Inapplicable
Deal Type: Inapplicable December 06, 2024

Lead Product(s) : AFA-281,Ethanol
Therapeutic Area : Psychiatry/Psychology
Highest Development Status : Phase I
Partner/Sponsor/Collaborator : Undisclosed
Deal Size : Inapplicable
Deal Type : Inapplicable
A Phase I Study of the Interaction of Alcohol With Oral AFA-281 in Healthy Volunteers
Details : AFA-281 is a drug candidate, which is currently being evaluated in phase I clinical studies for the treatment of Alcoholism.
Product Name : Undisclosed
Product Type : Undisclosed
Upfront Cash : Inapplicable
December 06, 2024

Details:
Alcohol is a Other Small Molecule drug candidate, which is currently being evaluated in phase I clinical studies for the treatment of Alcoholism.
Lead Product(s): Ethanol,PT150
Therapeutic Area: Psychiatry/Psychology Brand Name: Undisclosed
Study Phase: Phase IProduct Type: Miscellaneous
Sponsor: University of Kentucky | National Institute on Alcohol Abuse and Alcoholism
Deal Size: Inapplicable Upfront Cash: Inapplicable
Deal Type: Inapplicable December 02, 2024

Lead Product(s) : Ethanol,PT150
Therapeutic Area : Psychiatry/Psychology
Highest Development Status : Phase I
Partner/Sponsor/Collaborator : University of Kentucky | National Institute on Alcohol Abuse and Alcoholism
Deal Size : Inapplicable
Deal Type : Inapplicable
PT150 Drug for Use in Alcohol Use Disorder
Details : Alcohol is a Other Small Molecule drug candidate, which is currently being evaluated in phase I clinical studies for the treatment of Alcoholism.
Product Name : Undisclosed
Product Type : Miscellaneous
Upfront Cash : Inapplicable
December 02, 2024

Boost your online visibility by uploading your products, APIs, FDFs, intermediates, excipients, and services for free on PharmaCompass.
Rank higher among suppliers and expand your reach across the internet efficiently and cost-effectively.
Details:
Mino-Lok (MLT) is a novel antibiotic lock therapy that combines minocycline with edetate disodium, which is investigated for the treatment of patients with catheter-related blood stream infections.
Lead Product(s): Minocycline Hydrochloride,Edetate Calcium Disodium,Ethanol
Therapeutic Area: Infections and Infectious Diseases Brand Name: Mino-Lok
Study Phase: Phase IIIProduct Type: Miscellaneous
Sponsor: Undisclosed
Deal Size: Inapplicable Upfront Cash: Inapplicable
Deal Type: Inapplicable November 25, 2024

Boost your online visibility by uploading your products, APIs, FDFs, intermediates, excipients, and services for free on PharmaCompass.
Rank higher among suppliers and expand your reach across the internet efficiently and cost-effectively.
Lead Product(s) : Minocycline Hydrochloride,Edetate Calcium Disodium,Ethanol
Therapeutic Area : Infections and Infectious Diseases
Highest Development Status : Phase III
Partner/Sponsor/Collaborator : Undisclosed
Deal Size : Inapplicable
Deal Type : Inapplicable
Citius Holds FDA Type C Meeting On Phase 3 Mino-Lok® Pathway for Approval
Details : Mino-Lok (MLT) is a novel antibiotic lock therapy that combines minocycline with edetate disodium, which is investigated for the treatment of patients with catheter-related blood stream infections.
Product Name : Mino-Lok
Product Type : Miscellaneous
Upfront Cash : Inapplicable
November 25, 2024

Boost your online visibility by uploading your products, APIs, FDFs, intermediates, excipients, and services for free on PharmaCompass.
Rank higher among suppliers and expand your reach across the internet efficiently and cost-effectively.
Details:
Mino-Lok (MLT) is a novel antibiotic lock therapy that combines minocycline with edetate disodium, which is investigated for the treatment of patients with catheter-related blood stream infections.
Lead Product(s): Minocycline Hydrochloride,Edetate Calcium Disodium,Ethanol
Therapeutic Area: Infections and Infectious Diseases Brand Name: Mino-Lok
Study Phase: Phase IIIProduct Type: Miscellaneous
Sponsor: Undisclosed
Deal Size: Inapplicable Upfront Cash: Inapplicable
Deal Type: Inapplicable May 21, 2024

Boost your online visibility by uploading your products, APIs, FDFs, intermediates, excipients, and services for free on PharmaCompass.
Rank higher among suppliers and expand your reach across the internet efficiently and cost-effectively.
Lead Product(s) : Minocycline Hydrochloride,Edetate Calcium Disodium,Ethanol
Therapeutic Area : Infections and Infectious Diseases
Highest Development Status : Phase III
Partner/Sponsor/Collaborator : Undisclosed
Deal Size : Inapplicable
Deal Type : Inapplicable
Citius Pharma Hits Key Goals in Phase 3 Trial of Mino-Lok Antibiotic Lock Solution
Details : Mino-Lok (MLT) is a novel antibiotic lock therapy that combines minocycline with edetate disodium, which is investigated for the treatment of patients with catheter-related blood stream infections.
Product Name : Mino-Lok
Product Type : Miscellaneous
Upfront Cash : Inapplicable
May 21, 2024

Boost your online visibility by uploading your products, APIs, FDFs, intermediates, excipients, and services for free on PharmaCompass.
Rank higher among suppliers and expand your reach across the internet efficiently and cost-effectively.
Details:
Mino-Lok (MLT) is a novel antibiotic lock therapy that combines minocycline with edetate disodium, which is investigated for the treatment of patients with catheter-related blood stream infections.
Lead Product(s): Minocycline Hydrochloride,Edetate Calcium Disodium,Ethanol
Therapeutic Area: Infections and Infectious Diseases Brand Name: Mino-Lok
Study Phase: Phase IIIProduct Type: Miscellaneous
Sponsor: Undisclosed
Deal Size: Inapplicable Upfront Cash: Inapplicable
Deal Type: Inapplicable January 02, 2024

Boost your online visibility by uploading your products, APIs, FDFs, intermediates, excipients, and services for free on PharmaCompass.
Rank higher among suppliers and expand your reach across the internet efficiently and cost-effectively.
Lead Product(s) : Minocycline Hydrochloride,Edetate Calcium Disodium,Ethanol
Therapeutic Area : Infections and Infectious Diseases
Highest Development Status : Phase III
Partner/Sponsor/Collaborator : Undisclosed
Deal Size : Inapplicable
Deal Type : Inapplicable
Citius Completes Enrollment In Pivotal Phase 3 Trial Of Mino-Lok To Salvage Catheters
Details : Mino-Lok (MLT) is a novel antibiotic lock therapy that combines minocycline with edetate disodium, which is investigated for the treatment of patients with catheter-related blood stream infections.
Product Name : Mino-Lok
Product Type : Miscellaneous
Upfront Cash : Inapplicable
January 02, 2024

FULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]
Boost your online visibility by uploading your products, APIs, FDFs, intermediates, excipients, and services for free on PharmaCompass.
Rank higher among suppliers and expand your reach across the internet efficiently and cost-effectively.
Regulatory Info : Originator
Registration Country : South Africa
Brand Name : Merthiolate Spray
Dosage Form : SPO
Dosage Strength : 52.799ml
Packaging : 30X1mg
Approval Date :
Application Number :
Regulatory Info : Originator
Registration Country : South Africa
Boost your online visibility by uploading your products, APIs, FDFs, intermediates, excipients, and services for free on PharmaCompass.
Rank higher among suppliers and expand your reach across the internet efficiently and cost-effectively.
Regulatory Info : Generic
Registration Country : South Africa
Brand Name : Entress Druppels
Dosage Form : DRP
Dosage Strength : 61.67% v/v/5ml
Packaging : 20X1ml/5ml
Approval Date :
Application Number :
Regulatory Info : Generic
Registration Country : South Africa
Boost your online visibility by uploading your products, APIs, FDFs, intermediates, excipients, and services for free on PharmaCompass.
Rank higher among suppliers and expand your reach across the internet efficiently and cost-effectively.
Regulatory Info : Originator
Registration Country : South Africa
Brand Name : Lennon Ipekakuanha Tinktuur
Dosage Form : LIQ
Dosage Strength : 18.899% v/v/5ml
Packaging : 20X1ml/5ml
Approval Date :
Application Number :
Regulatory Info : Originator
Registration Country : South Africa
Boost your online visibility by uploading your products, APIs, FDFs, intermediates, excipients, and services for free on PharmaCompass.
Rank higher among suppliers and expand your reach across the internet efficiently and cost-effectively.
Regulatory Info : Generic
Registration Country : South Africa
Brand Name : Stuipdruppels Dm
Dosage Form : DRP
Dosage Strength : 56.28%
Packaging : 20X1ml/5ml
Approval Date :
Application Number :
Regulatory Info : Generic
Registration Country : South Africa
Boost your online visibility by uploading your products, APIs, FDFs, intermediates, excipients, and services for free on PharmaCompass.
Rank higher among suppliers and expand your reach across the internet efficiently and cost-effectively.
Regulatory Info : RX
Registration Country : USA
Brand Name : DEHYDRATED ALCOHOL
Dosage Form : SOLUTION;INTRA-ARTERIAL
Dosage Strength : 99% (5ML)
Packaging :
Approval Date : 2025-06-23
Application Number : 219444
Regulatory Info : RX
Registration Country : USA
Boost your online visibility by uploading your products, APIs, FDFs, intermediates, excipients, and services for free on PharmaCompass.
Rank higher among suppliers and expand your reach across the internet efficiently and cost-effectively.
Regulatory Info : OTC
Registration Country : USA
ALCOHOL; CHLORHEXIDINE GLUCONATE
Brand Name : AVAGARD
Dosage Form : SOLUTION;TOPICAL
Dosage Strength : 61%;1%
Packaging :
Approval Date : 2001-06-07
Application Number : 21074
Regulatory Info : OTC
Registration Country : USA

Boost your online visibility by uploading your products, APIs, FDFs, intermediates, excipients, and services for free on PharmaCompass.
Rank higher among suppliers and expand your reach across the internet efficiently and cost-effectively.
Regulatory Info : RX
Registration Country : USA
Brand Name : DEHYDRATED ALCOHOL
Dosage Form : SOLUTION;INTRA-ARTERIAL
Dosage Strength : 99% (5ML)
Packaging :
Approval Date : 2025-06-23
Application Number : 217845
Regulatory Info : RX
Registration Country : USA

Boost your online visibility by uploading your products, APIs, FDFs, intermediates, excipients, and services for free on PharmaCompass.
Rank higher among suppliers and expand your reach across the internet efficiently and cost-effectively.
Regulatory Info :
Registration Country : USA
Brand Name : ALCOHOL 5% AND DEXTROSE 5%
Dosage Form : INJECTABLE;INJECTION
Dosage Strength : 5ML/100ML;5GM/100ML
Packaging :
Approval Date :
Application Number : 4589
Regulatory Info :
Registration Country : USA

Boost your online visibility by uploading your products, APIs, FDFs, intermediates, excipients, and services for free on PharmaCompass.
Rank higher among suppliers and expand your reach across the internet efficiently and cost-effectively.
Regulatory Info : DISCN
Registration Country : USA
Brand Name : ABLYSINOL
Dosage Form : SOLUTION;INTRA-ARTERIAL
Dosage Strength : 99% (1ML) **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons**
Packaging :
Approval Date : 2018-06-21
Application Number : 207987
Regulatory Info : DISCN
Registration Country : USA

Boost your online visibility by uploading your products, APIs, FDFs, intermediates, excipients, and services for free on PharmaCompass.
Rank higher among suppliers and expand your reach across the internet efficiently and cost-effectively.
Regulatory Info : RX
Registration Country : USA
Brand Name : ABLYSINOL
Dosage Form : SOLUTION;INTRA-ARTERIAL
Dosage Strength : 99% (5ML)
Packaging :
Approval Date : 2018-06-21
Application Number : 207987
Regulatory Info : RX
Registration Country : USA

FULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]
Boost your online visibility by uploading your products, APIs, FDFs, intermediates, excipients, and services for free on PharmaCompass.
Rank higher among suppliers and expand your reach across the internet efficiently and cost-effectively.
RLD : No
TE Code : AP
Brand Name : DEHYDRATED ALCOHOL
Dosage Form : SOLUTION;INTRA-ARTERIAL
Dosage Strength : 99% (5ML)
Approval Date : 2025-06-23
Application Number : 219444
RX/OTC/DISCN : RX
RLD : No
TE Code : AP
Boost your online visibility by uploading your products, APIs, FDFs, intermediates, excipients, and services for free on PharmaCompass.
Rank higher among suppliers and expand your reach across the internet efficiently and cost-effectively.
RLD : Yes
TE Code :
ALCOHOL; CHLORHEXIDINE GLUCONATE
Brand Name : AVAGARD
Dosage Form : SOLUTION;TOPICAL
Dosage Strength : 61%;1%
Approval Date : 2001-06-07
Application Number : 21074
RX/OTC/DISCN : OTC
RLD : Yes
TE Code :

Boost your online visibility by uploading your products, APIs, FDFs, intermediates, excipients, and services for free on PharmaCompass.
Rank higher among suppliers and expand your reach across the internet efficiently and cost-effectively.
RLD : No
TE Code : AP
Brand Name : DEHYDRATED ALCOHOL
Dosage Form : SOLUTION;INTRA-ARTERIAL
Dosage Strength : 99% (5ML)
Approval Date : 2025-06-23
Application Number : 217845
RX/OTC/DISCN : RX
RLD : No
TE Code : AP

Boost your online visibility by uploading your products, APIs, FDFs, intermediates, excipients, and services for free on PharmaCompass.
Rank higher among suppliers and expand your reach across the internet efficiently and cost-effectively.
RLD :
TE Code :
Brand Name : ALCOHOL 5% AND DEXTROSE 5%
Dosage Form : INJECTABLE;INJECTION
Dosage Strength : 5ML/100ML;5GM/100ML
Approval Date :
Application Number : 4589
RX/OTC/DISCN :
RLD :
TE Code :

Boost your online visibility by uploading your products, APIs, FDFs, intermediates, excipients, and services for free on PharmaCompass.
Rank higher among suppliers and expand your reach across the internet efficiently and cost-effectively.
RLD : Yes
TE Code :
Brand Name : ABLYSINOL
Dosage Form : SOLUTION;INTRA-ARTERIAL
Dosage Strength : 99% (1ML) **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons**
Approval Date : 2018-06-21
Application Number : 207987
RX/OTC/DISCN : DISCN
RLD : Yes
TE Code :

Boost your online visibility by uploading your products, APIs, FDFs, intermediates, excipients, and services for free on PharmaCompass.
Rank higher among suppliers and expand your reach across the internet efficiently and cost-effectively.
RLD : Yes
TE Code : AP
Brand Name : ABLYSINOL
Dosage Form : SOLUTION;INTRA-ARTERIAL
Dosage Strength : 99% (5ML)
Approval Date : 2018-06-21
Application Number : 207987
RX/OTC/DISCN : RX
RLD : Yes
TE Code : AP

Boost your online visibility by uploading your products, APIs, FDFs, intermediates, excipients, and services for free on PharmaCompass.
Rank higher among suppliers and expand your reach across the internet efficiently and cost-effectively.
RLD : No
TE Code : AP
Brand Name : DEHYDRATED ALCOHOL
Dosage Form : SOLUTION;INTRA-ARTERIAL
Dosage Strength : 99% (5ML)
Approval Date : 2025-07-09
Application Number : 219569
RX/OTC/DISCN : RX
RLD : No
TE Code : AP

Boost your online visibility by uploading your products, APIs, FDFs, intermediates, excipients, and services for free on PharmaCompass.
Rank higher among suppliers and expand your reach across the internet efficiently and cost-effectively.
RLD : Yes
TE Code :
Brand Name : DEHYDRATED ALCOHOL
Dosage Form : SOLUTION;INTRAVENOUS
Dosage Strength : 98% (5ML)
Approval Date : 2025-10-23
Application Number : 214988
RX/OTC/DISCN : RX
RLD : Yes
TE Code :

Boost your online visibility by uploading your products, APIs, FDFs, intermediates, excipients, and services for free on PharmaCompass.
Rank higher among suppliers and expand your reach across the internet efficiently and cost-effectively.
RLD : No
TE Code : AP
Brand Name : DEHYDRATED ALCOHOL
Dosage Form : SOLUTION;INTRA-ARTERIAL
Dosage Strength : 99% (5ML)
Approval Date : 2025-06-23
Application Number : 219400
RX/OTC/DISCN : RX
RLD : No
TE Code : AP

FULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]
Boost your online visibility by uploading your products, APIs, FDFs, intermediates, excipients, and services for free on PharmaCompass.
Rank higher among suppliers and expand your reach across the internet efficiently and cost-effectively.
Regulatory Info : Prescription
Registration Country : Denmark
Isosorbide Mononitrate; Diluted
Brand Name : Isomex
Dosage Form : Prolonged-Release Tablet
Dosage Strength : 30mg
Packaging :
Approval Date : 24-06-2025
Application Number : 28107379525
Regulatory Info : Prescription
Registration Country : Denmark

Boost your online visibility by uploading your products, APIs, FDFs, intermediates, excipients, and services for free on PharmaCompass.
Rank higher among suppliers and expand your reach across the internet efficiently and cost-effectively.
Regulatory Info :
Registration Country : Moldova
Brand Name : Alcool etilic - ElaDum 96%
Dosage Form : Cutaneous Solution
Dosage Strength :
Packaging :
Approval Date : 27-02-2023
Application Number :
Regulatory Info :
Registration Country : Moldova

Boost your online visibility by uploading your products, APIs, FDFs, intermediates, excipients, and services for free on PharmaCompass.
Rank higher among suppliers and expand your reach across the internet efficiently and cost-effectively.
Regulatory Info : Prescription
Registration Country : Denmark
Isosorbide Mononitrate; Diluted
Brand Name : Isomex
Dosage Form : Prolonged-Release Tablet
Dosage Strength : 30mg
Packaging :
Approval Date : 15-09-2022
Application Number : 28106809122
Regulatory Info : Prescription
Registration Country : Denmark

Boost your online visibility by uploading your products, APIs, FDFs, intermediates, excipients, and services for free on PharmaCompass.
Rank higher among suppliers and expand your reach across the internet efficiently and cost-effectively.
Regulatory Info : Prescription
Registration Country : Denmark
Isosorbide Mononitrate; Diluted
Brand Name : Isomex
Dosage Form : Prolonged-Release Tablet
Dosage Strength : 30mg
Packaging :
Approval Date : 17-02-2017
Application Number : 28105767416
Regulatory Info : Prescription
Registration Country : Denmark

Boost your online visibility by uploading your products, APIs, FDFs, intermediates, excipients, and services for free on PharmaCompass.
Rank higher among suppliers and expand your reach across the internet efficiently and cost-effectively.
Regulatory Info : Authorized
Registration Country : Spain
Cetylpyridinium Chloride; Ethanol (70%)
Brand Name : Alcomon Reinforced 70 degree Cutaneous Solution
Dosage Form : Cutaneous Solution
Dosage Strength : 70%
Packaging :
Approval Date : 01-03-1988
Application Number : 57571
Regulatory Info : Authorized
Registration Country : Spain

Boost your online visibility by uploading your products, APIs, FDFs, intermediates, excipients, and services for free on PharmaCompass.
Rank higher among suppliers and expand your reach across the internet efficiently and cost-effectively.
Regulatory Info : Authorized
Registration Country : Spain
Cetylpyridinium Chloride; Ethanol (96%)
Brand Name : Alcomon Reinforced 96 degree Cutaneous Solution
Dosage Form : Cutaneous Solution
Dosage Strength : 96%
Packaging :
Approval Date : 01-03-1988
Application Number : 57570
Regulatory Info : Authorized
Registration Country : Spain

Boost your online visibility by uploading your products, APIs, FDFs, intermediates, excipients, and services for free on PharmaCompass.
Rank higher among suppliers and expand your reach across the internet efficiently and cost-effectively.
Regulatory Info : Cancelled
Registration Country : Spain
Chlorhexidine Digluconate; Ethanol
Brand Name : Reinforced Menalcol 96 degree Skin Solution
Dosage Form : Cutaneous Solution
Dosage Strength :
Packaging :
Approval Date : 01-03-1990
Application Number : 58717
Regulatory Info : Cancelled
Registration Country : Spain

Boost your online visibility by uploading your products, APIs, FDFs, intermediates, excipients, and services for free on PharmaCompass.
Rank higher among suppliers and expand your reach across the internet efficiently and cost-effectively.
Regulatory Info : Authorized
Registration Country : Spain
Chlorhexidine Digluconate; Ethanol
Brand Name : Reinforced Menalcol 70 degree Skin Solution
Dosage Form : Cutaneous Solution
Dosage Strength :
Packaging :
Approval Date : 01-03-1990
Application Number : 58716
Regulatory Info : Authorized
Registration Country : Spain

Regulatory Info : Withdrawn
Registration Country : Malta
Cassia Senna; Ethanol; Charcoal
Brand Name : Eucarbon Herbal
Dosage Form : Tablet
Dosage Strength : 105MG; 70%V/V; 180MG
Packaging :
Approval Date : 2022-01-06
Application Number :
Regulatory Info : Withdrawn
Registration Country : Malta

Portfolio PDF
Product Web Link
Virtual Booth
Digital Content
Website
Corporate PDF
Regulatory Info : Withdrawn
Registration Country : Malta
Brand Name : Dehydrated Alcohol (Absolute Alcohol) Bp
Dosage Form : Solution For Injection
Dosage Strength : 100%V/V
Packaging :
Approval Date : 2016-09-12
Application Number :
Regulatory Info : Withdrawn
Registration Country : Malta

Portfolio PDF
Product Web Link
Virtual Booth
Digital Content
Website
Corporate PDF
FULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]
Boost your online visibility by uploading your products, APIs, FDFs, intermediates, excipients, and services for free on PharmaCompass.
Rank higher among suppliers and expand your reach across the internet efficiently and cost-effectively.
Regulatory Info : NON-PRESCRIPTION DRUGS
Registration Country : Canada
Brand Name : SEPTI-WIPES
Dosage Form : WIPE
Dosage Strength : 50%/W/V
Packaging :
Approval Date :
Application Number : 2505266
Regulatory Info : NON-PRESCRIPTION DRUGS
Registration Country : Canada

Boost your online visibility by uploading your products, APIs, FDFs, intermediates, excipients, and services for free on PharmaCompass.
Rank higher among suppliers and expand your reach across the internet efficiently and cost-effectively.
Regulatory Info : NON-PRESCRIPTION DRUGS
Registration Country : Canada
Brand Name : GERMXTRA
Dosage Form : SPRAY
Dosage Strength : 79%/W/W
Packaging : 700ML/946ML/4L
Approval Date :
Application Number : 2239248
Regulatory Info : NON-PRESCRIPTION DRUGS
Registration Country : Canada

Boost your online visibility by uploading your products, APIs, FDFs, intermediates, excipients, and services for free on PharmaCompass.
Rank higher among suppliers and expand your reach across the internet efficiently and cost-effectively.
Regulatory Info : NON-PRESCRIPTION DRUGS
Registration Country : Canada
Brand Name : ULTRA SWIPES
Dosage Form : WIPE
Dosage Strength : 79%/W/W
Packaging : 160 (619G)
Approval Date :
Application Number : 2267276
Regulatory Info : NON-PRESCRIPTION DRUGS
Registration Country : Canada

Boost your online visibility by uploading your products, APIs, FDFs, intermediates, excipients, and services for free on PharmaCompass.
Rank higher among suppliers and expand your reach across the internet efficiently and cost-effectively.
Regulatory Info : NON-PRESCRIPTION DRUGS
Registration Country : Canada
Brand Name : UKAL-TOWEL
Dosage Form : WIPE
Dosage Strength : 50%/W/V
Packaging :
Approval Date :
Application Number : 2428806
Regulatory Info : NON-PRESCRIPTION DRUGS
Registration Country : Canada

Boost your online visibility by uploading your products, APIs, FDFs, intermediates, excipients, and services for free on PharmaCompass.
Rank higher among suppliers and expand your reach across the internet efficiently and cost-effectively.
Regulatory Info : NON-PRESCRIPTION DRUGS
Registration Country : Canada
Brand Name : TB MINUTEMAN (READY TO USE TOWELETTES)
Dosage Form : WIPE
Dosage Strength : 79%
Packaging : 160
Approval Date :
Application Number : 2282461
Regulatory Info : NON-PRESCRIPTION DRUGS
Registration Country : Canada

Boost your online visibility by uploading your products, APIs, FDFs, intermediates, excipients, and services for free on PharmaCompass.
Rank higher among suppliers and expand your reach across the internet efficiently and cost-effectively.
Regulatory Info : NON-PRESCRIPTION DRUGS
Registration Country : Canada
Brand Name : TB MINUTEMAN NEX GEN DISINFECTANT WIPES
Dosage Form : WIPE
Dosage Strength : 6.84%/W/W
Packaging :
Approval Date :
Application Number : 2488973
Regulatory Info : NON-PRESCRIPTION DRUGS
Registration Country : Canada

Boost your online visibility by uploading your products, APIs, FDFs, intermediates, excipients, and services for free on PharmaCompass.
Rank higher among suppliers and expand your reach across the internet efficiently and cost-effectively.
Regulatory Info : NON-PRESCRIPTION DRUGS
Registration Country : Canada
Brand Name : CAVIWIPES 1
Dosage Form : WIPE
Dosage Strength : 7.5%/W/W
Packaging :
Approval Date :
Application Number : 2379759
Regulatory Info : NON-PRESCRIPTION DRUGS
Registration Country : Canada

Boost your online visibility by uploading your products, APIs, FDFs, intermediates, excipients, and services for free on PharmaCompass.
Rank higher among suppliers and expand your reach across the internet efficiently and cost-effectively.
Regulatory Info : NON-PRESCRIPTION DRUGS
Registration Country : Canada
Brand Name : BIOSURF - LIQ HOS
Dosage Form : LIQUID
Dosage Strength : 70.5%
Packaging : 60/500/700ML/6L
Approval Date :
Application Number : 2209756
Regulatory Info : NON-PRESCRIPTION DRUGS
Registration Country : Canada

Boost your online visibility by uploading your products, APIs, FDFs, intermediates, excipients, and services for free on PharmaCompass.
Rank higher among suppliers and expand your reach across the internet efficiently and cost-effectively.
Regulatory Info : NON-PRESCRIPTION DRUGS
Registration Country : Canada
Brand Name : WAHL SPRAY ON DISINFECTANT
Dosage Form : LIQUID
Dosage Strength : 70%/W/W
Packaging : 240ML
Approval Date :
Application Number : 2338521
Regulatory Info : NON-PRESCRIPTION DRUGS
Registration Country : Canada

Boost your online visibility by uploading your products, APIs, FDFs, intermediates, excipients, and services for free on PharmaCompass.
Rank higher among suppliers and expand your reach across the internet efficiently and cost-effectively.
Regulatory Info : NON-PRESCRIPTION DRUGS
Registration Country : Canada
Brand Name : LYSOL BRAND II DISINFECTANT SPRAY
Dosage Form : AEROSOL
Dosage Strength : 58%/W/W
Packaging : 26G TO 680G
Approval Date :
Application Number : 2448971
Regulatory Info : NON-PRESCRIPTION DRUGS
Registration Country : Canada

FULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]
Boost your online visibility by uploading your products, APIs, FDFs, intermediates, excipients, and services for free on PharmaCompass.
Rank higher among suppliers and expand your reach across the internet efficiently and cost-effectively.
Regulatory Info : Originator
Registration Country : South Africa
Brand Name : Merthiolate Spray
Dosage Form : SPO
Dosage Strength : 52.799ml
Packaging : 30X1mg
Approval Date :
Application Number :
Regulatory Info : Originator
Registration Country : South Africa
Boost your online visibility by uploading your products, APIs, FDFs, intermediates, excipients, and services for free on PharmaCompass.
Rank higher among suppliers and expand your reach across the internet efficiently and cost-effectively.
Regulatory Info : Generic
Registration Country : South Africa
Brand Name : Entress Druppels
Dosage Form : DRP
Dosage Strength : 61.67% v/v/5ml
Packaging : 20X1ml/5ml
Approval Date :
Application Number :
Regulatory Info : Generic
Registration Country : South Africa
Boost your online visibility by uploading your products, APIs, FDFs, intermediates, excipients, and services for free on PharmaCompass.
Rank higher among suppliers and expand your reach across the internet efficiently and cost-effectively.
Regulatory Info : Originator
Registration Country : South Africa
Brand Name : Lennon Ipekakuanha Tinktuur
Dosage Form : LIQ
Dosage Strength : 18.899% v/v/5ml
Packaging : 20X1ml/5ml
Approval Date :
Application Number :
Regulatory Info : Originator
Registration Country : South Africa
Boost your online visibility by uploading your products, APIs, FDFs, intermediates, excipients, and services for free on PharmaCompass.
Rank higher among suppliers and expand your reach across the internet efficiently and cost-effectively.
Regulatory Info : Generic
Registration Country : South Africa
Brand Name : Stuipdruppels Dm
Dosage Form : DRP
Dosage Strength : 56.28%
Packaging : 20X1ml/5ml
Approval Date :
Application Number :
Regulatory Info : Generic
Registration Country : South Africa
Boost your online visibility by uploading your products, APIs, FDFs, intermediates, excipients, and services for free on PharmaCompass.
Rank higher among suppliers and expand your reach across the internet efficiently and cost-effectively.
Regulatory Info : Generic
Registration Country : South Africa
Brand Name : Lcc-Peppermint Cough Mixture
Dosage Form : SYR
Dosage Strength : 100mg
Packaging : 100X1mg
Approval Date :
Application Number :
Regulatory Info : Generic
Registration Country : South Africa

Boost your online visibility by uploading your products, APIs, FDFs, intermediates, excipients, and services for free on PharmaCompass.
Rank higher among suppliers and expand your reach across the internet efficiently and cost-effectively.
Regulatory Info : Generic
Registration Country : South Africa
Brand Name : Lcc-Peppermint Cough Mixture
Dosage Form : SYR
Dosage Strength : 100mg
Packaging : 50X1mg
Approval Date :
Application Number :
Regulatory Info : Generic
Registration Country : South Africa

Boost your online visibility by uploading your products, APIs, FDFs, intermediates, excipients, and services for free on PharmaCompass.
Rank higher among suppliers and expand your reach across the internet efficiently and cost-effectively.
Regulatory Info : Originator
Registration Country : South Africa
Brand Name : GEES LINCTUS
Dosage Form : LIQ
Dosage Strength : 20% w/v
Packaging : 500X1%
Approval Date :
Application Number :
Regulatory Info : Originator
Registration Country : South Africa

FULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]
Boost your online visibility by uploading your products, APIs, FDFs, intermediates, excipients, and services for free on PharmaCompass.
Rank higher among suppliers and expand your reach across the internet efficiently and cost-effectively.
Regulatory Info :
Registration Country : Israel
Brand Name :
Dosage Form : Spray
Dosage Strength : 70%
Packaging :
Approval Date :
Application Number :
Regulatory Info :
Registration Country : Israel

Boost your online visibility by uploading your products, APIs, FDFs, intermediates, excipients, and services for free on PharmaCompass.
Rank higher among suppliers and expand your reach across the internet efficiently and cost-effectively.
Packaging :
Regulatory Info :
Dosage : Spray
Dosage Strength : 70%
Brand Name :
Approval Date :
Application Number :
Registration Country : Israel

Boost your online visibility by uploading your products, APIs, FDFs, intermediates, excipients, and services for free on PharmaCompass.
Rank higher among suppliers and expand your reach across the internet efficiently and cost-effectively.
Regulatory Info :
Registration Country : Singapore
Brand Name : Hygin-X Antiseptic Han...
Dosage Form : Handrub Gel
Dosage Strength : 75%
Packaging :
Approval Date :
Application Number :
Regulatory Info :
Registration Country : Singapore

Boost your online visibility by uploading your products, APIs, FDFs, intermediates, excipients, and services for free on PharmaCompass.
Rank higher among suppliers and expand your reach across the internet efficiently and cost-effectively.
Packaging :
Regulatory Info :
Dosage : Handrub Gel
Dosage Strength : 75%
Brand Name : Hygin-X Antiseptic Han...
Approval Date :
Application Number :
Registration Country : Singapore

Boost your online visibility by uploading your products, APIs, FDFs, intermediates, excipients, and services for free on PharmaCompass.
Rank higher among suppliers and expand your reach across the internet efficiently and cost-effectively.
Regulatory Info :
Registration Country : Singapore
Povidone Iodine; Denatured alcohol
Brand Name : Povidone Iodine 10%
Dosage Form : Alcoholic Solution
Dosage Strength : 10%; 70%
Packaging :
Approval Date :
Application Number :
Regulatory Info :
Registration Country : Singapore

Boost your online visibility by uploading your products, APIs, FDFs, intermediates, excipients, and services for free on PharmaCompass.
Rank higher among suppliers and expand your reach across the internet efficiently and cost-effectively.
Packaging :
Regulatory Info :
Povidone Iodine; Denatured alcohol
Dosage : Alcoholic Solution
Dosage Strength : 10%; 70%
Brand Name : Povidone Iodine 10%
Approval Date :
Application Number :
Registration Country : Singapore

Boost your online visibility by uploading your products, APIs, FDFs, intermediates, excipients, and services for free on PharmaCompass.
Rank higher among suppliers and expand your reach across the internet efficiently and cost-effectively.
Regulatory Info :
Registration Country : Singapore
Brand Name : Septanol Disinfectant ...
Dosage Form : Solution
Dosage Strength : 70%
Packaging :
Approval Date :
Application Number :
Regulatory Info :
Registration Country : Singapore

Boost your online visibility by uploading your products, APIs, FDFs, intermediates, excipients, and services for free on PharmaCompass.
Rank higher among suppliers and expand your reach across the internet efficiently and cost-effectively.
Packaging :
Regulatory Info :
Dosage : Solution
Dosage Strength : 70%
Brand Name : Septanol Disinfectant ...
Approval Date :
Application Number :
Registration Country : Singapore

Boost your online visibility by uploading your products, APIs, FDFs, intermediates, excipients, and services for free on PharmaCompass.
Rank higher among suppliers and expand your reach across the internet efficiently and cost-effectively.
Regulatory Info :
Registration Country : South Korea
Salicylic Acid; Allantoin; Ethanol
Brand Name : Acnemedi Spray
Dosage Form : Spray
Dosage Strength : 0.5%; 0.2%; 22.84%
Packaging :
Approval Date :
Application Number :
Regulatory Info :
Registration Country : South Korea

Boost your online visibility by uploading your products, APIs, FDFs, intermediates, excipients, and services for free on PharmaCompass.
Rank higher among suppliers and expand your reach across the internet efficiently and cost-effectively.
Packaging :
Regulatory Info :
Salicylic Acid; Allantoin; Ethanol
Dosage : Spray
Dosage Strength : 0.5%; 0.2%; 22.84%
Brand Name : Acnemedi Spray
Approval Date :
Application Number :
Registration Country : South Korea

Boost your online visibility by uploading your products, APIs, FDFs, intermediates, excipients, and services for free on PharmaCompass.
Rank higher among suppliers and expand your reach across the internet efficiently and cost-effectively.
Regulatory Info :
Registration Country : Saudi Arabia
Brand Name : Septiraz
Dosage Form : Gel
Dosage Strength : 70%
Packaging :
Approval Date :
Application Number :
Regulatory Info :
Registration Country : Saudi Arabia

Boost your online visibility by uploading your products, APIs, FDFs, intermediates, excipients, and services for free on PharmaCompass.
Rank higher among suppliers and expand your reach across the internet efficiently and cost-effectively.
Packaging :
Regulatory Info :
Dosage : Gel
Dosage Strength : 70%
Brand Name : Septiraz
Approval Date :
Application Number :
Registration Country : Saudi Arabia

Boost your online visibility by uploading your products, APIs, FDFs, intermediates, excipients, and services for free on PharmaCompass.
Rank higher among suppliers and expand your reach across the internet efficiently and cost-effectively.
Regulatory Info :
Registration Country : India
Minoxidil; Tretinoin; Azelaic Acid; alcohol
Brand Name :
Dosage Form : Topical Solution
Dosage Strength : 2%; 0.010%; 1.5%; 65%
Packaging :
Approval Date :
Application Number :
Regulatory Info :
Registration Country : India

Boost your online visibility by uploading your products, APIs, FDFs, intermediates, excipients, and services for free on PharmaCompass.
Rank higher among suppliers and expand your reach across the internet efficiently and cost-effectively.
Packaging :
Regulatory Info :
Minoxidil; Tretinoin; Azelaic Acid; alcohol
Dosage : Topical Solution
Dosage Strength : 2%; 0.010%; 1.5%; 65%
Brand Name :
Approval Date :
Application Number :
Registration Country : India

Boost your online visibility by uploading your products, APIs, FDFs, intermediates, excipients, and services for free on PharmaCompass.
Rank higher among suppliers and expand your reach across the internet efficiently and cost-effectively.
Regulatory Info :
Registration Country : India
Minoxidil; Tretinoin; Azelaic Acid; alcohol
Brand Name :
Dosage Form : Topical Solution
Dosage Strength : 5%; 0.010%; 1.5%; 38%
Packaging :
Approval Date :
Application Number :
Regulatory Info :
Registration Country : India

Boost your online visibility by uploading your products, APIs, FDFs, intermediates, excipients, and services for free on PharmaCompass.
Rank higher among suppliers and expand your reach across the internet efficiently and cost-effectively.
Packaging :
Regulatory Info :
Minoxidil; Tretinoin; Azelaic Acid; alcohol
Dosage : Topical Solution
Dosage Strength : 5%; 0.010%; 1.5%; 38%
Brand Name :
Approval Date :
Application Number :
Registration Country : India

Boost your online visibility by uploading your products, APIs, FDFs, intermediates, excipients, and services for free on PharmaCompass.
Rank higher among suppliers and expand your reach across the internet efficiently and cost-effectively.
Regulatory Info :
Registration Country : India
Brand Name :
Dosage Form : Topical Solution
Dosage Strength : 75MG; 40%
Packaging :
Approval Date :
Application Number :
Regulatory Info :
Registration Country : India

Boost your online visibility by uploading your products, APIs, FDFs, intermediates, excipients, and services for free on PharmaCompass.
Rank higher among suppliers and expand your reach across the internet efficiently and cost-effectively.
Packaging :
Regulatory Info :
Dosage : Topical Solution
Dosage Strength : 75MG; 40%
Brand Name :
Approval Date :
Application Number :
Registration Country : India

Boost your online visibility by uploading your products, APIs, FDFs, intermediates, excipients, and services for free on PharmaCompass.
Rank higher among suppliers and expand your reach across the internet efficiently and cost-effectively.
Regulatory Info :
Registration Country : India
Brand Name :
Dosage Form : Topical Solution
Dosage Strength : 20MG; 40%
Packaging :
Approval Date :
Application Number :
Regulatory Info :
Registration Country : India

Boost your online visibility by uploading your products, APIs, FDFs, intermediates, excipients, and services for free on PharmaCompass.
Rank higher among suppliers and expand your reach across the internet efficiently and cost-effectively.
Packaging :
Regulatory Info :
Dosage : Topical Solution
Dosage Strength : 20MG; 40%
Brand Name :
Approval Date :
Application Number :
Registration Country : India

FULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]Related Excipient Companies
Dosage Form : Tablet
Grade : Oral
Dosage Form : Cream / Lotion / Ointment
Grade : Topical, Parenteral
FULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]Dosage Form : Capsule
Grade : Oral, Topical
FULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]Dosage Form : Capsule
Grade : Oral
Application : Controlled & Modified Release
Excipient Details : EUDRAGIT® L 100 (powder), a delayed release polymer is used to increase solubility of poorly soluble products such as tablets, capsules, ODTs, etc.
Pharmacopoeia Ref : NA
Technical Specs : NA
Ingredient(s) : Methacrylic Acid Methyl Methacrylate Copolymer
Dosage Form : Tablet
Grade : Oral
Application : Solubilizers
Excipient Details : EUDRAGIT® L 12,5 (organic solution), a delayed release polymer is used to increase solubility of poorly soluble products such as tablets and capsules.
Pharmacopoeia Ref : NA
Technical Specs : NA
Ingredient(s) : Methacrylic Acid Methyl Methacrylate Copolymer
Dosage Form : Tablet
Grade : Oral
Application : Solubilizers
Excipient Details : EUDRAGIT® S 12,5 (Organic solution) a delayed release polymer, used to increase solubility of poorly soluble drugs such as tablets and capsules.
Pharmacopoeia Ref : NA
Technical Specs : NA
Ingredient(s) : Methacrylic Acid Methyl Methacrylate Copolymer
Dosage Form : Orodispersible Tablet
Grade : Oral, Topical
Application : Disintegrants & Superdisintegrants
Excipient Details : Glycine is used as a disintegrant in solid dosage forms such as orally disintegrating tablets and in topical formulations such as emulsions & creams.
Pharmacopoeia Ref : NA
Technical Specs : Molecular weight: 75.07 g/mol
Ingredient(s) : Glycine Excipient
Dosage Form : Gel
Grade : Topical
Application : Topical
Excipient Details : L-Alanine is used in topical semi-solid dosage forms such as creams, lotions, ointments, gels, etc.
Dosage Form : Gel
Grade : Topical
Application : Topical
Excipient Details : L-Aspartic Acid is widely used in topical dosage forms such as creams, gels, ointments and lotions.
Pharmacopoeia Ref : NA
Technical Specs : Molecular weight: 133.1 g/mol
Ingredient(s) : L-Aspartic Acid
Dosage Form : Cream / Lotion / Ointment
Grade : Topical
Application : Topical
Excipient Details : L-Phenylalanine is used as an excipient in a variety of topical dosage forms such as cream, lotion, gel, etc.
Pharmacopoeia Ref : NA
Technical Specs : Molecular weight: 165.19 g/mol
Ingredient(s) : L-Phenylalanine
Dosage Form : Injectable / Parenteral
Grade : Parenteral
Dosage Form : Gel
Grade : Topical
Application : Topical
Excipient Details : L-Serine is used in topical semi-solid formulations such as creams, lotions and gel.
Dosage Form : Gel
Grade : Topical
Application : Topical
Excipient Details : L-Threonine is used in semi-solid topical formulations such as lotion, cream, gel and ointment.
Pharmacopoeia Ref : NA
Technical Specs : Molecular weight: 119.1 g/mol
Ingredient(s) : L Threonine Excipient
FULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]Dosage Form : Tablet
Grade : Oral
Application : Taste Masking
Excipient Details : Mannitol is used as a filler, bulking agent and taste masking agent in ODT formulations such as tablets.
Dosage Form : Tablet
Grade : Oral
Dosage Form : Capsule
Grade : Oral
FULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]Dosage Form : Tablet
Grade : Oral
Application : Controlled & Modified Release
Excipient Details : ACTILLETS are microcrystalline cellulose spheres developed using advanced drug delivery technology to enable effective loading & coating of particles.
Pharmacopoeia Ref : NA
Technical Specs : Not Available
Ingredient(s) : Microcrystalline Cellulose Excipients
Dosage Form : Tablet
Grade : Oral
Dosage Form : Tablet
Grade : Oral
Dosage Form : Tablet
Grade : Oral
Application : Taste Masking
Excipient Details : CM90 is a directly compressible, granulated calcium carbonate with maltodextrin used for swallow tablets due to its high density and compressibility.
Pharmacopoeia Ref : NA
Technical Specs : PSD D50: 490- 500 µm; Tapped Density: 1.50
Ingredient(s) : Calcium Carbonate Excipient
Dosage Form : Tablet
Grade : Oral
Dosage Form : Tablet
Grade : Oral
Application : Taste Masking
Excipient Details : CS90 is a directly compressible calcium carbonate with starch used for chewable tablets due to its smooth mouthfeel and creamy texture.
Pharmacopoeia Ref : NA
Technical Specs : PSD D50: 150-175 µm, Tapped Density: 0.85
Ingredient(s) : Calcium Carbonate Excipient
Dosage Form : Tablet
Grade : Oral
Application : Direct Compression
Excipient Details : DC SIM 100 is a directly compressible simethicone powder used for antacid and anti-gas tablets.
Dosage Form : Tablet
Grade : Oral
Application : Disintegrants & Superdisintegrants
Excipient Details : Mannogem 2080 exhibits excellent flow, disintegration and compression properties.
Dosage Form : Orodispersible Tablet
Grade : Oral
Dosage Form : Tablet
Grade : Oral
FULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]Dosage Form : Tablet
Grade : Oral
Dosage Form : Tablet
Grade : Oral
Application : Fillers, Diluents & Binders
Excipient Details : Microlose (Lactose Monohydrate & Microcrystalline Cellulose) is used as a diluent in oral dosage forms such as tablets.
Pharmacopoeia Ref : USP-NF,BP,EP,IP
Technical Specs : Lactose Monohydrate – 40%, Microcrystalline cellulose – 60%
Ingredient(s) : Lactose Monohydrate
Dosage Form : Tablet
Grade : Oral
Dosage Form : Capsule
Grade : Oral
Application : Fillers, Diluents & Binders
Excipient Details : ProBlend (SMCC) is a co-processed excipient consists of microcrystalline cellulose & colloidal silicon dioxide, used as a diluent & binder in OSDs.
Pharmacopoeia Ref : USP-NF,BP,EP,IP
Technical Specs : NA
Ingredient(s) : Microcrystalline Cellulose Excipients
Dosage Form : Softgels
Grade : Oral
Dosage Form : Tablet
Grade : Oral
Application : Fillers, Diluents & Binders
Excipient Details : Starlose P40 (Starch & Lactose Monohydrate) is used as a diluent in oral dosage forms such as tablets.
FULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]Dosage Form : Gel
Grade : Parenteral, Oral, Topical
Dosage Form : Injectable / Parenteral
Grade : Parenteral
Application : Parenteral
Excipient Details : Castor oil is used as an oily solvent in parenteral dosage forms.
Dosage Form : Tablet
Grade : Oral, Topical
Dosage Form : Cream / Lotion / Ointment
Grade : Topical
Dosage Form : Ophthalmic Solution
Grade : Parenteral
Brand Name : Hydroxypropyl Guar
Application : Parenteral
Excipient Details : Hydroxypropyl guar is used as a viscosity-enhancing agent and lubricant in ophthalmic formulations.
Dosage Form : Emulsion
Grade : Parenteral, Topical
Dosage Form : Cream / Lotion / Ointment
Grade : Parenteral, Oral, Topical
Dosage Form : Cream / Lotion / Ointment
Grade : Topical, Oral
Dosage Form : Injectable / Parenteral
Grade : Parenteral, Oral, Topical
Dosage Form : Injectable / Parenteral
Grade : Parenteral, Oral, Topical
FULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]Dosage Form : Tablet
Grade : Oral, Parenteral
Application : Controlled & Modified Release
Excipient Details : PLGA-PEG is used in the synthesis of targeted nanoparticles which are used for differential delivery and controlled release of drugs.
Pharmacopoeia Ref : NA
Technical Specs : Nano-particles, ultrapure, low-monomer & powder grades.
Ingredient(s) : Poly-DL-Lactic-co-Glycolic Acid
Dosage Form : Tablet
Grade : Oral, Parenteral
Application : Controlled & Modified Release
Excipient Details : PLLA-PEG used in the synthesis of targeted nanoparticles which are used for differential delivery and controlled release of drugs.
Pharmacopoeia Ref : NA
Technical Specs : Nano-particles, ultrapure, low-monomer & powder grades
Ingredient(s) : Poly L Lactic Acid
FULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]Dosage Form : Tablet
Grade : Oral
Application : Fillers, Diluents & Binders
Pharmacopoeia Ref : EP./USP.NF
Technical Specs : NA
Ingredient(s) : Microcrystalline Cellulose Excipients
FULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]Dosage Form : Tablet
Grade : Oral
Dosage Form : Softgels
Grade : Oral, Topical, Parenteral
Dosage Form : Injectable / Parenteral
Grade : Parenteral
Dosage Form : Tablet
Grade : Oral
Dosage Form : Tablet
Grade : Oral
FULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]Dosage Form : Capsule
Grade : Oral
Application : Fillers, Diluents & Binders
Pharmacopoeia Ref : IP/BP/USP/EP
Technical Specs : NA
Ingredient(s) : Microcrystalline Cellulose Excipients
FULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]Dosage Form : Tablet
Grade : Not Available
Brand Name : Hydroxypropyl Methyl Cell...
Application : Coating Systems & Additives
Pharmacopoeia Ref : Not Available
Technical Specs : Not Available
Ingredient(s) : Hydroxypropyl Methyl Cellulose
FULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]Dosage Form : Inhalation
Grade : Inhalation
Application : Empty Capsules
Excipient Details : Quali-V®-I is the first plant-based capsule that responds to the particular functional properties required for use in dry powder inhaler (DPI) devices.
Pharmacopoeia Ref : Not Available
Technical Specs : Not Available
Ingredient(s) : Hydroxypropyl Methyl Cellulose
Dosage Form : Clinical Supply
Grade : Oral
FULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]Dosage Form : Tablet
Grade : Not Available
Dosage Form : Tablet
Grade : Not Available
Dosage Form : Softgel Capsule
Grade : Not Available
Application : Soft Gelatin
Dosage Form : Tablet
Grade : Not Available
Application : Fillers, Diluents & Binders
Excipient Details : It is a high-performance wet granulation binder for swallowable tablets with low impact on dissolution
Dosage Form : Tablet
Grade : Not Available
Application : Fillers, Diluents & Binders
Excipient Details : It is a natural pregelatinized maize starch that has been specially developed as a binder for wet granulation.
Dosage Form : Tablet
Grade : Not Available
Application : Disintegrants & Superdisintegrants
Excipient Details : Used as disintegrants, fillers and binders (once cooked) in nutraceutical and pharmaceutical dosage forms.
Dosage Form : Tablet
Grade : Not Available
Application : Fillers, Diluents & Binders
Excipient Details : Helps to manufacture Oral Dosage and Nutraceutical forms by acting as a filler-binder while serving as a fibre source for your customers.
Pharmacopoeia Ref : EP/USP/JP
Technical Specs : Not Available
Ingredient(s) : Microcrystalline Cellulose Excipients
Dosage Form : Injectable / Parenteral
Grade : Not Available
Application : Parenteral
Excipient Details : A pyrogen-free sorbitol used as a carbohydrate source and osmotic diuretic agent in large volume parenteral injectables.
Dosage Form : Tablet
Grade : Not Available
Application : Fillers, Diluents & Binders
Excipient Details : Its range offers a unique blend of exceptional physical and chemical stability and no hygroscopicity.
Dosage Form : Tablet
Grade : Not Available
Application : Fillers, Diluents & Binders
Excipient Details : Used as disintegrants, fillers and binders (once cooked) in nutraceutical and pharmaceutical dosage forms.
FULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]Dosage Form : Tablet
Grade : Oral
Application : Solubilizers
Excipient Details : It is used as a suspending agent.
Pharmacopoeia Ref : Not Available
Technical Specs : Not Available
Ingredient(s) : Polyacrylic Acid Excipient
Dosage Form : Capsule
Grade : Oral
Application : Fillers, Diluents & Binders
Excipient Details : It is used as an adhesive agent.
Pharmacopoeia Ref : Not Available
Technical Specs : Also Available as AnyCoat®-C AN3, AN4, AN5, AN6, AN15, AN50, BN4
Ingredient(s) : Hydroxypropyl Methyl Cellulose
Dosage Form : Tablet
Grade : Oral
Application : Fillers, Diluents & Binders
Excipient Details : It is used as a filler in formulation.
Pharmacopoeia Ref : Not Available
Technical Specs : Also Available as Comprecel M102, M102CG, M103, M105, M124, M113, M200, M224, M301, M302
Ingredient(s) : Microcrystalline Cellulose Excipients
Dosage Form : Tablet
Grade : Oral
Application : Fillers, Diluents & Binders
Excipient Details : It is used as a filler in formulation.
Dosage Form : Capsule
Grade : Oral
Application : Fillers, Diluents & Binders
Excipient Details : It is used as a filler in formulation.
FULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]Dosage Form : Tablet
Grade : Oral
Application : Granulation
Excipient Details : AceCel is suitable for majority of the directly compressible actives, combines good flow and high compressibility.
Pharmacopoeia Ref : Not Available
Technical Specs : Not Available
Ingredient(s) : Microcrystalline Cellulose Excipients
Dosage Form : Tablet
Grade : Oral
Application : Granulation
Excipient Details : HiCel acts as a strong dry binder. It facilitates low tablet friability & promotes rapid tablet disintegration.
Pharmacopoeia Ref : Not Available
Technical Specs : Not Available
Ingredient(s) : Microcrystalline Cellulose Excipients
Dosage Form : Tablet
Grade : Oral
Application : Co-Processed Excipients
Excipient Details : HiCel CE15 offers a superior mouthfeel with less chalkiness and gritness in chewable tablets and orally disintegrating tablets (ODTs).
Pharmacopoeia Ref : Not Available
Technical Specs : Not Available
Ingredient(s) : Guar Gum Excipient
Dosage Form : Tablet
Grade : Oral
Dosage Form : Tablet
Grade : Oral
Brand Name : HiCel MCC Spheres
Application : Co-Processed Excipients
Excipient Details : HiCel MCC Spheres are extremely versatile which are used for controlled release or sustained release formulations.
Pharmacopoeia Ref : Not Available
Technical Specs : Not Available
Ingredient(s) : Microcrystalline Cellulose Excipients
Dosage Form : Tablet
Grade : Oral
Application : Co-Processed Excipients
Excipient Details : HiCel MCG is use in oral suspensions as a stabilizer. It is a good binder for tablets & excellent thickener as well.
Pharmacopoeia Ref : Not Available
Technical Specs : Not Available
Ingredient(s) : Carboxymethyl Cellulose Sodium
Dosage Form : Tablet
Grade : Oral
Application : Co-Processed Excipients
Excipient Details : HiCel SMCC has unique combination which result in optimum compaction & superior flow properties.
Pharmacopoeia Ref : Not Available
Technical Specs : Not Available
Ingredient(s) : Microcrystalline Cellulose Excipients
Dosage Form : Tablet
Grade : Oral
Application : Granulation
Excipient Details : HiCellac is used in direct compression & dry granulation suitable for low dose formulations where API content uniformity is critical.
Pharmacopoeia Ref : Not Available
Technical Specs : Not Available
Ingredient(s) : Lactose Monohydrate
Dosage Form : Tablet
Grade : Oral
Application : Lubricants & Glidants
Excipient Details : Puretalc is used as a lubricant & diluent in oral solid dosage formulations such as tablets.
FULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]Dosage Form : Cream / Lotion / Ointment
Grade : Topical
Application : Topical
Excipient Details : Menthol is used in nasal sprays, topical gel patches and creams, and ointments.
FULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]Dosage Form : Tablet
Grade : Not Available
Brand Name : AFFINISOL HPMC HME
Application : Solubilizers
Excipient Details : Solubility enhancement, Spray-Dried Dispersion (SDD), Hot Melt Extrusion (HME)
Pharmacopoeia Ref : Not Available
Technical Specs : Not Available
Ingredient(s) : Hydroxypropyl Methyl Cellulose
Dosage Form : Tablet
Grade : Not Available
Dosage Form : Capsule
Grade : Not Available
Application : Rheology Modifiers
Excipient Details : Controlled Release, Direct Compression,Wet Granulation,Tablet Coating, Liquid Solutions and Suspensions
Pharmacopoeia Ref : Not Available
Technical Specs : Not Available
Ingredient(s) : Hydroxypropyl Methyl Cellulose
FULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]Dosage Form : Cream / Lotion / Ointment
Grade : Topical
Dosage Form : Solution
Grade : Oral, Topical
Application : Solubilizers
Excipient Details : Hydrosol 50 is used as a solubilizer and emulsifying agent in oral and topical liquid and semi-solid dosage forms.
Pharmacopoeia Ref : USP/NF
Technical Specs : N/A
Ingredient(s) : Polyoxyl 40 Hydrogenated Castor Oil
FULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]Dosage Form : Capsule
Grade : Oral
FULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]Dosage Form : Granule / Pellet
Grade : Oral
Excipients Web Link
FULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]Dosage Form : Syrup
Grade : Oral and Topical
Application : Taste Masking
Excipients Web Link
Dosage Form : Tablet
Grade : Oral & Topical
Application : Taste Masking
FULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]Excipients by Applications
Dosage Form : Cream / Lotion / Ointment, Injectable / Parenteral
Grade : Topical, Parenteral
Category : Parenteral, Topical
Application : Topical
Excipient Details : L-Alanine is used in topical semi-solid dosage forms such as creams, lotions, ointments, gels, etc.
Dosage Form : Capsule, Orodispersible Tablet, Tablet
Grade : Oral
Category : Chewable & Orodispersible Aids, Coating Systems & Additives, Fillers, Diluents & Binders
Dosage Form : Capsule, Cream / Lotion / Ointment, Emulsion, Gel, Injectable / Parenteral, Suspension, Tablet
Grade : Parenteral, Oral, Topical
Category : Emulsifying Agents, Film Formers & Plasticizers, Parenteral, Solubilizers, Surfactant & Foaming Agents, Thickeners and Stabilizers, Topical
Application : Emulsifying Agents, Film Formers & Plasticizers, Parenteral, Solubilizers, Surfactant & Foaming Agents, Thickeners and Stabilizers, Topical
Excipient Details : Polysorbate 80 is used as a plasticizer, solubilizer, emulsifier, surfactant, and suspension stabilizer. It is also used in parenteral products.
Dosage Form : Cream / Lotion / Ointment, Emulsion, Gel, Injectable / Parenteral, Suspension, Tablet
Grade : Parenteral, Oral, Topical
Category : Emulsifying Agents, Parenteral, Solubilizers, Surfactant & Foaming Agents, Thickeners and Stabilizers, Topical
Application : Parenteral
Excipient Details : Used as a nitrogen source in cell culture media in upstream. use for vaccines, recombinant proteins, antibodies manufacturing.
Pharmacopoeia Ref : On Request
Technical Specs : Low bacteria endotoxins, low bioburden (TAMC/TYMC). Customised pa...
Ingredient(s) : L-Aspartic Acid
Dosage Form : Injectable / Parenteral
Grade : Biopharma Grade
Category : Emulsifying Agents, Parenteral
Application : Emulsifying Agents, Parenteral
Excipient Details : Used as a fatty acid in cell culture media in upstream. Also used as an emulsifier and stabilizer in final formulation.
Pharmacopoeia Ref : On Request
Technical Specs : Low bacteria endotoxins, low bioburden (TAMC/TYMC). Customised pa...
Ingredient(s) : Oleic Acid Excipient
Application : Parenteral, Solubilizers
Excipient Details : Solubilizer agent, increasing solubility of hydrophobic peptides and proteins and denaturing proteins. Also used in cell cultures as a nutrient.
Pharmacopoeia Ref : On Request
Technical Specs : Low bacteria endotoxins, low bioburden (TAMC/TYMC). Customised pa...
Ingredient(s) : Urea
Application : Parenteral
Excipient Details : Used as an ingredient in cell culture media in upstream, as a buffer elution in downstream and as a buffering agent in formulations.
Pharmacopoeia Ref : On Request
Technical Specs : Low bacteria endotoxins, low bioburden (TAMC/TYMC). Customised pa...
Ingredient(s) : Glycine Excipient
Application : Topical
Excipient Details : L-Aspartic Acid is widely used in topical dosage forms such as creams, gels, ointments and lotions.
Pharmacopoeia Ref : NA
Technical Specs : Molecular weight: 133.1 g/mol
Ingredient(s) : L-Aspartic Acid
Application : Fillers, Diluents & Binders, Taste Masking
Excipient Details : Mannitol is used as a filler, bulking agent and taste masking agent in ODT formulations such as tablets.
Dosage Form : Orodispersible Tablet, Tablet
Grade : Oral
Category : Chewable & Orodispersible Aids, Direct Compression, Fillers, Diluents & Binders, Taste Masking
Application : Chewable & Orodispersible Aids, Direct Compression, Fillers, Diluents & Binders, Taste Masking
Excipient Details : CS90 is a directly compressible calcium carbonate with starch used for chewable tablets due to its smooth mouthfeel and creamy texture.
Pharmacopoeia Ref : NA
Technical Specs : PSD D50: 150-175 µm, Tapped Density: 0.85
Ingredient(s) : Calcium Carbonate Excipient
Dosage Form : Granule / Pellet, Tablet
Grade : Oral
Category : Fillers, Diluents & Binders, Granulation, Solubilizers
Dosage Form : Cream / Lotion / Ointment, Gel, Injectable / Parenteral, Softgel Capsule, Softgels
Grade : Parenteral, Topical, Oral
Category : Fillers, Diluents & Binders, Film Formers & Plasticizers, Parenteral, Surfactant & Foaming Agents, Thickeners and Stabilizers, Topical
Brand Name : Polyethylene Glycol 400
Application : Fillers, Diluents & Binders, Film Formers & Plasticizers, Parenteral, Surfactant & Foaming Agents, Thickeners and Stabilizers, Topical
Excipient Details : PEG 400 is used as a suspending agent, stabilizer, plasticizer and filler in OSDs, liquids & semi-solids and as a solvent for parenteral formulations.
Dosage Form : Injectable / Parenteral, Tablet
Grade : Parenteral, Oral
Category : Fillers, Diluents & Binders, Parenteral, Thickeners and Stabilizers
Application : Fillers, Diluents & Binders, Parenteral, Thickeners and Stabilizers
Excipient Details : D-Mannitol protects proteins from denaturation & degradation. It is used as a stabilizer in liquid products including biologic injectables & vaccines.
Pharmacopoeia Ref : USP, EP, BP, JP, ChP
Technical Specs : Low Endotoxin, Low Metals
Ingredient(s) : Mannitol
Dosage Form : Orodispersible Tablet, Tablet
Grade : Oral
Category : Chewable & Orodispersible Aids, Direct Compression, Fillers, Diluents & Binders, Taste Masking
Dosage Form : Capsule, Orodispersible Tablet, Tablet
Grade : Oral
Category : Chewable & Orodispersible Aids, Coating Systems & Additives, Fillers, Diluents & Binders
Grade : Oral
Category : Co-Processed Excipients, Fillers, Diluents & Binders
Application : Co-Processed Excipients, Fillers, Diluents & Binders
Excipient Details : ProBlend (SMCC) is a co-processed excipient consists of microcrystalline cellulose & colloidal silicon dioxide, used as a diluent & binder in OSDs.
Pharmacopoeia Ref : USP-NF,BP,EP,IP
Technical Specs : NA
Ingredient(s) : Microcrystalline Cellulose Excipients
Application : Controlled & Modified Release, Solubilizers
Excipient Details : EUDRAGIT® L 100 (powder), a delayed release polymer is used to increase solubility of poorly soluble products such as tablets, capsules, ODTs, etc.
Pharmacopoeia Ref : NA
Technical Specs : NA
Ingredient(s) : Methacrylic Acid Methyl Methacrylate Copolymer
Dosage Form : Granule / Pellet, Tablet
Grade : Oral
Category : Fillers, Diluents & Binders, Granulation, Solubilizers
Dosage Form : Cream / Lotion / Ointment, Emulsion, Gel, Injectable / Parenteral, Suspension, Tablet
Grade : Parenteral, Oral, Topical
Category : Emulsifying Agents, Parenteral, Solubilizers, Surfactant & Foaming Agents, Thickeners and Stabilizers, Topical
Dosage Form : Cream / Lotion / Ointment, Gel, Tablet
Grade : Oral, Topical
Category : Solubilizers, Topical
Application : Parenteral, Solubilizers
Excipient Details : Solubilizer agent, increasing solubility of hydrophobic peptides and proteins and denaturing proteins. Also used in cell cultures as a nutrient.
Pharmacopoeia Ref : On Request
Technical Specs : Low bacteria endotoxins, low bioburden (TAMC/TYMC). Customised pa...
Ingredient(s) : Urea
Dosage Form : Cream / Lotion / Ointment, Emulsion, Gel, Suspension
Grade : Topical, Oral
Category : Emulsifying Agents, Solubilizers, Surfactant & Foaming Agents, Thickeners and Stabilizers, Topical
Application : Solubilizers
Excipient Details : EUDRAGIT® L 12,5 (organic solution), a delayed release polymer is used to increase solubility of poorly soluble products such as tablets and capsules.
Pharmacopoeia Ref : NA
Technical Specs : NA
Ingredient(s) : Methacrylic Acid Methyl Methacrylate Copolymer
Dosage Form : Cream / Lotion / Ointment, Tablet
Grade : Oral, Topical
Category : Emulsifying Agents, Solubilizers
Brand Name : Polyoxyethylene Hydrogenated Castor Oil
Application : Emulsifying Agents, Solubilizers
Excipient Details : Polyoxyl 40 hydrogenated castor oil is used as a solubilizer and emulsifier in oral and topical formulations.
Pharmacopoeia Ref : ChP/USP/EP
Technical Specs : NA
Ingredient(s) : Polyoxyl 40 Hydrogenated Castor Oil
Application : Solubilizers
Excipient Details : EUDRAGIT® S 12,5 (Organic solution) a delayed release polymer, used to increase solubility of poorly soluble drugs such as tablets and capsules.
Pharmacopoeia Ref : NA
Technical Specs : NA
Ingredient(s) : Methacrylic Acid Methyl Methacrylate Copolymer
Dosage Form : Cream / Lotion / Ointment
Grade : Topical
Category : Emulsifying Agents, Film Formers & Plasticizers, Solubilizers, Thickeners and Stabilizers
Dosage Form : Capsule, Cream / Lotion / Ointment, Emulsion, Gel, Injectable / Parenteral, Suspension, Tablet
Grade : Parenteral, Oral, Topical
Category : Emulsifying Agents, Film Formers & Plasticizers, Parenteral, Solubilizers, Surfactant & Foaming Agents, Thickeners and Stabilizers, Topical
Application : Emulsifying Agents, Film Formers & Plasticizers, Parenteral, Solubilizers, Surfactant & Foaming Agents, Thickeners and Stabilizers, Topical
Excipient Details : Polysorbate 80 is used as a plasticizer, solubilizer, emulsifier, surfactant, and suspension stabilizer. It is also used in parenteral products.
Dosage Form : Cream / Lotion / Ointment, Emulsion, Gel, Injectable / Parenteral, Suspension, Tablet
Grade : Parenteral, Oral, Topical
Category : Emulsifying Agents, Parenteral, Solubilizers, Surfactant & Foaming Agents, Thickeners and Stabilizers, Topical
Dosage Form : Injectable / Parenteral, Tablet
Grade : Parenteral, Oral
Category : Fillers, Diluents & Binders, Parenteral, Thickeners and Stabilizers
Application : Fillers, Diluents & Binders, Parenteral, Thickeners and Stabilizers
Excipient Details : D-Mannitol protects proteins from denaturation & degradation. It is used as a stabilizer in liquid products including biologic injectables & vaccines.
Pharmacopoeia Ref : USP, EP, BP, JP, ChP
Technical Specs : Low Endotoxin, Low Metals
Ingredient(s) : Mannitol
Dosage Form : Injectable / Parenteral
Grade : Parenteral
Category : Parenteral, Thickeners and Stabilizers
Application : Parenteral, Thickeners and Stabilizers
Excipient Details : Sucrose is used to stabilize proteins, lipids, carbohydrates, ADCs & vaccines. It is also used as a cryopreservative in cell-based bioprocesses.
Pharmacopoeia Ref : USP NF, EP, JP, ChP
Technical Specs : Low Endotoxin, Low Metals
Ingredient(s) : Saccharose Excipient
Dosage Form : Injectable / Parenteral
Grade : Biopharma Grade
Category : API Stability Enhancers, Thickeners and Stabilizers
Application : API Stability Enhancers, Thickeners and Stabilizers
Excipient Details : Used to stabilize proteins in injectable biologic formulations. Also used as a nutrient for cell culture media in upstream.
Pharmacopoeia Ref : On Request
Technical Specs : Low bacteria endotoxins, low bioburden (TAMC/TYMC). Customised pa...
Ingredient(s) : L-Arginine Excipient
Dosage Form : Injectable / Parenteral
Grade : Biopharma Grade
Category : Emulsifying Agents, Thickeners and Stabilizers
Application : Emulsifying Agents, Thickeners and Stabilizers
Excipient Details : Used as a fatty acid in cell culture media in upstream. Also used as an emulsifier and stabilizer in final formulation.
Pharmacopoeia Ref : On Request
Technical Specs : Low bacteria endotoxins, low bioburden (TAMC/TYMC). Customised pa...
Ingredient(s) : Stearic Acid
Dosage Form : Injectable / Parenteral
Grade : Biopharma Grade
Category : Parenteral, Thickeners and Stabilizers
Brand Name : Citric Acid Monohydrate
Application : Parenteral, Thickeners and Stabilizers
Excipient Details : Used as a pH regulator and preservative in many Biological formulations and cell culture media. Also it can be used as a chelating agent.
Pharmacopoeia Ref : On Request
Technical Specs : Low bacteria endotoxins, low bioburden (TAMC/TYMC). Customised pa...
Ingredient(s) : Citric Acid Excipient
Dosage Form : Injectable / Parenteral
Grade : Parenteral
Category : Parenteral, Thickeners and Stabilizers
Application : Parenteral, Thickeners and Stabilizers
Excipient Details : L-Arginine is used as a cryoprotective agent and solution additive to stabilize proteins. It is used in injectable biologic & vaccine formulations.
Pharmacopoeia Ref : USP, EP, JP, ChP
Technical Specs : Low Endotoxin, Low Metals
Ingredient(s) : L-Arginine Excipient
Application : Parenteral
Excipient Details : Amino acid used for protein synthesis and cellular metabolism in cell culture media in upstream process.
Pharmacopoeia Ref : On Request
Technical Specs : Low bacteria endotoxins, low bioburden (TAMC/TYMC). Customised pa...
Ingredient(s) : L-Proline
Dosage Form : Capsule, Orodispersible Tablet, Tablet
Grade : Oral
Category : Chewable & Orodispersible Aids, Coating Systems & Additives, Fillers, Diluents & Binders
Dosage Form : Tablet
Grade : Oral
Category : Coating Systems & Additives, Controlled & Modified Release
Application : Coating Systems & Additives, Controlled & Modified Release
Excipient Details : ACTILLETS are microcrystalline cellulose spheres developed using advanced drug delivery technology to enable effective loading & coating of particles.
Pharmacopoeia Ref : NA
Technical Specs : Not Available
Ingredient(s) : Microcrystalline Cellulose Excipients
Grade : Not Available
Category : Coating Systems & Additives, Film Formers & Plasticizers
Dosage Form : Emulsion, Tablet
Grade : Oral, Ophthalmic
Category : Disintegrants & Superdisintegrants, Emulsifying Agents, Film Formers & Plasticizers, Thickeners and Stabilizers
Brand Name : Hydroxypropyl Methyl Cellulose
Application : Disintegrants & Superdisintegrants, Emulsifying Agents, Film Formers & Plasticizers, Thickeners and Stabilizers
Excipient Details : Hydroxypropyl Methyl Cellulose is used as a film-former, disintegrant, thickener, and emulsifier in tablets, emulsions, and ophthalmic formulations.
Brand Name : Hydroxypropyl Methyl Cellulose
Application : Coating Systems & Additives
Pharmacopoeia Ref : Not Available
Technical Specs : Not Available
Ingredient(s) : Hydroxypropyl Methyl Cellulose
Dosage Form : Tablet
Grade : Oral
Category : Coating Systems & Additives, Controlled & Modified Release
Application : Coating Systems & Additives, Controlled & Modified Release
Excipient Details : Ecopol L 100 is used as an enteric/delayed release coating system and for drug delivery in the small intestine.
Pharmacopoeia Ref : Not Available
Technical Specs : Not Available
Ingredient(s) : Methacrylic Acid Methyl Methacrylate Copolymer
Application : Coating Systems & Additives
Excipient Details : Acrycoat L 12.5 is used as an enteric coated Drug delivery system.
Pharmacopoeia Ref : Ph.Eur.: Methacrylic Acid - Me...
Technical Specs : Not Available
Ingredient(s) : Methacrylic Acid Methyl Methacrylate Copolymer
Dosage Form : Granule / Pellet, Tablet
Grade : Oral
Category : Coating Systems & Additives, Fillers, Diluents & Binders, Film Formers & Plasticizers
Dosage Form : Cream / Lotion / Ointment, Emulsion
Grade : Topical
Category : Coating Systems & Additives, Rheology Modifiers, Topical
Application : Coating Systems & Additives, Rheology Modifiers, Topical
Excipient Details : Polyglykol 400 is a liquid PEG excipient grade product which is used as solvent, humectant, coating agent and viscosity enhancer.
Pharmacopoeia Ref : USP-NF: Polyethylene glycol 40...
Technical Specs : average molar mass 400 g/mol
Ingredient(s) : Polyethylene Glycol 400
Dosage Form : Cream / Lotion / Ointment, Injectable / Parenteral
Grade : Topical, Parenteral
Category : Parenteral, Topical
Application : Topical
Excipient Details : L-Alanine is used in topical semi-solid dosage forms such as creams, lotions, ointments, gels, etc.
Application : Fillers, Diluents & Binders, Taste Masking
Excipient Details : Mannitol is used as a filler, bulking agent and taste masking agent in ODT formulations such as tablets.
Brand Name : Hydroxypropyl Guar
Application : Parenteral
Excipient Details : Hydroxypropyl guar is used as a viscosity-enhancing agent and lubricant in ophthalmic formulations.
Dosage Form : Cream / Lotion / Ointment, Emulsion, Gel, Injectable / Parenteral, Suspension, Tablet
Grade : Parenteral, Oral, Topical
Category : Emulsifying Agents, Parenteral, Solubilizers, Surfactant & Foaming Agents, Thickeners and Stabilizers, Topical
Dosage Form : Injectable / Parenteral
Grade : Parenteral
Category : Parenteral, Thickeners and Stabilizers
Application : Parenteral, Thickeners and Stabilizers
Excipient Details : Sucrose is used to stabilize proteins, lipids, carbohydrates, ADCs & vaccines. It is also used as a cryopreservative in cell-based bioprocesses.
Pharmacopoeia Ref : USP NF, EP, JP, ChP
Technical Specs : Low Endotoxin, Low Metals
Ingredient(s) : Saccharose Excipient
Application : Parenteral, Solubilizers
Excipient Details : Solubilizer agent, increasing solubility of hydrophobic peptides and proteins and denaturing proteins. Also used in cell cultures as a nutrient.
Pharmacopoeia Ref : On Request
Technical Specs : Low bacteria endotoxins, low bioburden (TAMC/TYMC). Customised pa...
Ingredient(s) : Urea
Dosage Form : Injectable / Parenteral
Grade : Biopharma Grade
Category : Parenteral, Thickeners and Stabilizers
Brand Name : Citric Acid Monohydrate
Application : Parenteral, Thickeners and Stabilizers
Excipient Details : Used as a pH regulator and preservative in many Biological formulations and cell culture media. Also it can be used as a chelating agent.
Pharmacopoeia Ref : On Request
Technical Specs : Low bacteria endotoxins, low bioburden (TAMC/TYMC). Customised pa...
Ingredient(s) : Citric Acid Excipient
Dosage Form : Injectable / Parenteral
Grade : Biopharma Grade
Category : Emulsifying Agents, Parenteral
Application : Emulsifying Agents, Parenteral
Excipient Details : Used as a fatty acid in cell culture media in upstream. Also used as an emulsifier and stabilizer in final formulation.
Pharmacopoeia Ref : On Request
Technical Specs : Low bacteria endotoxins, low bioburden (TAMC/TYMC). Customised pa...
Ingredient(s) : Oleic Acid Excipient
Application : Controlled & Modified Release, Solubilizers
Excipient Details : EUDRAGIT® L 100 (powder), a delayed release polymer is used to increase solubility of poorly soluble products such as tablets, capsules, ODTs, etc.
Pharmacopoeia Ref : NA
Technical Specs : NA
Ingredient(s) : Methacrylic Acid Methyl Methacrylate Copolymer
Dosage Form : Tablet
Grade : Oral
Category : Coating Systems & Additives, Controlled & Modified Release
Application : Coating Systems & Additives, Controlled & Modified Release
Excipient Details : ACTILLETS are microcrystalline cellulose spheres developed using advanced drug delivery technology to enable effective loading & coating of particles.
Pharmacopoeia Ref : NA
Technical Specs : Not Available
Ingredient(s) : Microcrystalline Cellulose Excipients
Dosage Form : Cream / Lotion / Ointment, Tablet
Grade : Oral, Topical
Category : Controlled & Modified Release, Film Formers & Plasticizers, Thickeners and Stabilizers
Brand Name : Cetostearyl Alcohol
Application : Controlled & Modified Release, Film Formers & Plasticizers, Thickeners and Stabilizers
Excipient Details : Cetostearyl alcohol is used as a material for extended release in oral formulations and as a base, thickener, and plasticizer in topical formulations.
Dosage Form : Cream / Lotion / Ointment, Gel, Injectable / Parenteral, Softgel Capsule, Softgels
Grade : Parenteral, Topical, Oral
Category : Fillers, Diluents & Binders, Film Formers & Plasticizers, Parenteral, Surfactant & Foaming Agents, Thickeners and Stabilizers, Topical
Brand Name : Polyethylene Glycol 400
Application : Fillers, Diluents & Binders, Film Formers & Plasticizers, Parenteral, Surfactant & Foaming Agents, Thickeners and Stabilizers, Topical
Excipient Details : PEG 400 is used as a suspending agent, stabilizer, plasticizer and filler in OSDs, liquids & semi-solids and as a solvent for parenteral formulations.
Application : Controlled & Modified Release
Excipient Details : PLLA-PEG used in the synthesis of targeted nanoparticles which are used for differential delivery and controlled release of drugs.
Pharmacopoeia Ref : NA
Technical Specs : Nano-particles, ultrapure, low-monomer & powder grades
Ingredient(s) : Poly L Lactic Acid
Dosage Form : Capsule, Orodispersible Tablet, Tablet
Grade : Not Available
Category : Controlled & Modified Release, Granulation, Taste Masking
Dosage Form : Granule / Pellet, Tablet
Grade : Oral & Topical
Category : Controlled & Modified Release, Lubricants & Glidants
Application : Controlled & Modified Release, Lubricants & Glidants
Excipient Details : Talc is a widely used as a dissolution retardant in the development of controlled release products. Talc is also used as a lubricant in tablet formulations.
Excipients Web Link
Dosage Form : Capsule, Cream / Lotion / Ointment, Tablet
Grade : Not Available
Category : Controlled & Modified Release, Solubilizers, Thickeners and Stabilizers, Topical
Brand Name : Glyceryl Monostearate
Application : Controlled & Modified Release, Solubilizers, Thickeners and Stabilizers, Topical
Excipient Details : Glyceryl monostearate is used as an emollient, solubilizer, stabilizer, emulsifier, and sustained-release agent in tablets and capsules.
Pharmacopoeia Ref : Not Available
Technical Specs : Not Available
Ingredient(s) : Glyceryl Monostearate
Application : Controlled & Modified Release
Excipient Details : PLGA-PEG is used in the synthesis of targeted nanoparticles which are used for differential delivery and controlled release of drugs.
Pharmacopoeia Ref : NA
Technical Specs : Nano-particles, ultrapure, low-monomer & powder grades.
Ingredient(s) : Poly-DL-Lactic-co-Glycolic Acid
Dosage Form : Tablet
Grade : Oral
Category : Coating Systems & Additives, Controlled & Modified Release
Application : Coating Systems & Additives, Controlled & Modified Release
Excipient Details : Ecopol L 100 is used as an enteric/delayed release coating system and for drug delivery in the small intestine.
Pharmacopoeia Ref : Not Available
Technical Specs : Not Available
Ingredient(s) : Methacrylic Acid Methyl Methacrylate Copolymer
Dosage Form : Tablet
Grade : Oral
Category : Chewable & Orodispersible Aids, Co-Processed Excipients, Direct Compression, Taste Masking
Dosage Form : Orodispersible Tablet, Tablet
Grade : Oral
Category : Chewable & Orodispersible Aids, Direct Compression, Disintegrants & Superdisintegrants
Brand Name : Mannogem Granular
Application : Chewable & Orodispersible Aids, Direct Compression, Disintegrants & Superdisintegrants
Excipient Details : Mannogem Granular has larger particles, offering a softer texture for chewable tablets and excellent flow, disintegration, and compression properties.
Dosage Form : Orodispersible Tablet, Tablet
Grade : Oral
Category : Chewable & Orodispersible Aids, Direct Compression, Taste Masking
Application : Chewable & Orodispersible Aids, Direct Compression, Taste Masking
Excipient Details : MS90 is a directly compressible magnesium hydroxide with starch used for chewable tablets due to its smooth mouthfeel and creamy texture.
Pharmacopoeia Ref : NA
Technical Specs : PSD D50: 150-170 µm, Tapped Density: 0.80
Ingredient(s) : Magnesium Hydroxide Excipient
Dosage Form : Orodispersible Tablet, Tablet
Grade : Oral
Category : Chewable & Orodispersible Aids, Direct Compression, Fillers, Diluents & Binders, Taste Masking
Dosage Form : Orodispersible Tablet, Tablet
Grade : Oral
Category : Chewable & Orodispersible Aids, Direct Compression, Fillers, Diluents & Binders, Taste Masking
Application : Chewable & Orodispersible Aids, Direct Compression, Fillers, Diluents & Binders, Taste Masking
Excipient Details : CS90 is a directly compressible calcium carbonate with starch used for chewable tablets due to its smooth mouthfeel and creamy texture.
Pharmacopoeia Ref : NA
Technical Specs : PSD D50: 150-175 µm, Tapped Density: 0.85
Ingredient(s) : Calcium Carbonate Excipient
Dosage Form : Tablet, Orodispersible Tablet
Grade : Oral
Category : Chewable & Orodispersible Aids, Co-Processed Excipients, Direct Compression, Disintegrants & Superdisintegrants, Fillers, Diluents & Binders, Taste Masking
Application : Chewable & Orodispersible Aids, Co-Processed Excipients, Direct Compression, Disintegrants & Superdisintegrants, Fillers, Diluents & Binders, Taste Masking
Excipient Details : Advantol® 300 is a DC pharmaceutical excipient used to create soft chew or fast melt oral dosage forms through co-processing technology.
Dosage Form : Tablet, Orodispersible Tablet
Grade : Oral
Category : Chewable & Orodispersible Aids, Co-Processed Excipients, Direct Compression, Fillers, Diluents & Binders, Taste Masking
Application : Chewable & Orodispersible Aids, Co-Processed Excipients, Direct Compression, Fillers, Diluents & Binders, Taste Masking
Excipient Details : Compressol® SM, co-processed polyol, is a DC excipient of mannitol & sorbitol with superior compactibility, low disintegration time & hygroscopicity.
Dosage Form : Tablet
Grade : Oral
Category : Direct Compression, Fillers, Diluents & Binders, Taste Masking
Application : Direct Compression, Fillers, Diluents & Binders, Taste Masking
Excipient Details : CM90 is a directly compressible, granulated calcium carbonate with maltodextrin used for swallow tablets due to its high density and compressibility.
Pharmacopoeia Ref : NA
Technical Specs : PSD D50: 490- 500 µm; Tapped Density: 1.50
Ingredient(s) : Calcium Carbonate Excipient
Dosage Form : Orodispersible Tablet, Tablet
Grade : Oral
Category : Chewable & Orodispersible Aids, Direct Compression, Fillers, Diluents & Binders, Taste Masking
Application : Direct Compression
Excipient Details : DC SIM 100 is a directly compressible simethicone powder used for antacid and anti-gas tablets.
Application : Fillers, Diluents & Binders, Taste Masking
Excipient Details : Mannitol is used as a filler, bulking agent and taste masking agent in ODT formulations such as tablets.
Dosage Form : Tablet
Grade : Oral
Category : Chewable & Orodispersible Aids, Co-Processed Excipients, Direct Compression, Taste Masking
Dosage Form : Orodispersible Tablet, Tablet
Grade : Oral
Category : Chewable & Orodispersible Aids, Direct Compression, Taste Masking
Application : Chewable & Orodispersible Aids, Direct Compression, Taste Masking
Excipient Details : MS90 is a directly compressible magnesium hydroxide with starch used for chewable tablets due to its smooth mouthfeel and creamy texture.
Pharmacopoeia Ref : NA
Technical Specs : PSD D50: 150-170 µm, Tapped Density: 0.80
Ingredient(s) : Magnesium Hydroxide Excipient
Grade : Oral
Category : Film Formers & Plasticizers, Surfactant & Foaming Agents, Taste Masking
Dosage Form : Capsule, Orodispersible Tablet, Tablet
Grade : Oral
Category : Chewable & Orodispersible Aids, Coating Systems & Additives, Fillers, Diluents & Binders
Dosage Form : Orodispersible Tablet, Tablet
Grade : Oral
Category : Chewable & Orodispersible Aids, Direct Compression, Fillers, Diluents & Binders, Taste Masking
Application : Chewable & Orodispersible Aids, Direct Compression, Fillers, Diluents & Binders, Taste Masking
Excipient Details : CS90 is a directly compressible calcium carbonate with starch used for chewable tablets due to its smooth mouthfeel and creamy texture.
Pharmacopoeia Ref : NA
Technical Specs : PSD D50: 150-175 µm, Tapped Density: 0.85
Ingredient(s) : Calcium Carbonate Excipient
Dosage Form : Orodispersible Tablet, Tablet
Grade : Oral
Category : Chewable & Orodispersible Aids, Direct Compression, Fillers, Diluents & Binders, Taste Masking
Dosage Form : Tablet, Orodispersible Tablet
Grade : Oral
Category : Chewable & Orodispersible Aids, Co-Processed Excipients, Direct Compression, Disintegrants & Superdisintegrants, Fillers, Diluents & Binders, Taste Masking
Application : Chewable & Orodispersible Aids, Co-Processed Excipients, Direct Compression, Disintegrants & Superdisintegrants, Fillers, Diluents & Binders, Taste Masking
Excipient Details : Advantol® 300 is a DC pharmaceutical excipient used to create soft chew or fast melt oral dosage forms through co-processing technology.
Dosage Form : Cream / Lotion / Ointment
Grade : Topical
Category : Emulsifying Agents, Film Formers & Plasticizers, Solubilizers, Thickeners and Stabilizers
Dosage Form : Capsule, Cream / Lotion / Ointment, Emulsion, Gel, Injectable / Parenteral, Suspension, Tablet
Grade : Parenteral, Oral, Topical
Category : Emulsifying Agents, Film Formers & Plasticizers, Parenteral, Solubilizers, Surfactant & Foaming Agents, Thickeners and Stabilizers, Topical
Application : Emulsifying Agents, Film Formers & Plasticizers, Parenteral, Solubilizers, Surfactant & Foaming Agents, Thickeners and Stabilizers, Topical
Excipient Details : Polysorbate 80 is used as a plasticizer, solubilizer, emulsifier, surfactant, and suspension stabilizer. It is also used in parenteral products.
Dosage Form : Cream / Lotion / Ointment, Gel, Injectable / Parenteral, Softgel Capsule, Softgels
Grade : Parenteral, Topical, Oral
Category : Fillers, Diluents & Binders, Film Formers & Plasticizers, Parenteral, Surfactant & Foaming Agents, Thickeners and Stabilizers, Topical
Brand Name : Polyethylene Glycol 400
Application : Fillers, Diluents & Binders, Film Formers & Plasticizers, Parenteral, Surfactant & Foaming Agents, Thickeners and Stabilizers, Topical
Excipient Details : PEG 400 is used as a suspending agent, stabilizer, plasticizer and filler in OSDs, liquids & semi-solids and as a solvent for parenteral formulations.
Dosage Form : Cream / Lotion / Ointment, Emulsion, Injectable / Parenteral, Softgels, Tablet
Grade : Oral, Topical, Parenteral
Category : Film Formers & Plasticizers, Parenteral, Topical
Dosage Form : Cream / Lotion / Ointment, Gel, Injectable / Parenteral, Softgels
Grade : Parenteral, Oral, Topical
Category : Film Formers & Plasticizers, Parenteral, Thickeners and Stabilizers, Topical
Dosage Form : Cream / Lotion / Ointment, Gel, Softgel Capsule, Softgels
Grade : Oral, Topical
Category : Fillers, Diluents & Binders, Film Formers & Plasticizers, Topical
Dosage Form : Capsule, Cream / Lotion / Ointment, Gel, Tablet
Grade : Topical, Oral
Category : Film Formers & Plasticizers, Lubricants & Glidants, Topical
Dosage Form : Granule / Pellet, Tablet
Grade : Oral
Category : Fillers, Diluents & Binders, Granulation, Solubilizers
Dosage Form : Tablet
Grade : Oral
Category : Granulation, Lubricants & Glidants, Surfactant & Foaming Agents
Dosage Form : Capsule, Orodispersible Tablet, Tablet
Grade : Not Available
Category : Controlled & Modified Release, Granulation, Taste Masking
Dosage Form : Tablet
Grade : Oral
Category : Direct Compression, Fillers, Diluents & Binders, Granulation
Application : Direct Compression, Fillers, Diluents & Binders, Granulation
Excipient Details : AceCel is suitable for majority of the directly compressible actives, combines good flow and high compressibility.
Pharmacopoeia Ref : Not Available
Technical Specs : Not Available
Ingredient(s) : Microcrystalline Cellulose Excipients
Dosage Form : Tablet
Grade : Oral
Category : Direct Compression, Fillers, Diluents & Binders, Granulation
Application : Direct Compression, Fillers, Diluents & Binders, Granulation
Excipient Details : HiCel acts as a strong dry binder. It facilitates low tablet friability & promotes rapid tablet disintegration.
Pharmacopoeia Ref : Not Available
Technical Specs : Not Available
Ingredient(s) : Microcrystalline Cellulose Excipients
Application : Fillers, Diluents & Binders, Granulation
Excipient Details : Fully Pregel Starch Corn is used as a binder in wet granulation in the manufacturing of tablets.
Application : Fillers, Diluents & Binders, Granulation
Pharmacopoeia Ref : EP./USP.NF
Technical Specs : NA
Ingredient(s) : Microcrystalline Cellulose Excipients
Grade : Not Available
Category : API Stability Enhancers, Coating Systems & Additives, Controlled & Modified Release, Direct Compression, Granulation, Rheology Modifiers, Vegetarian Capsules
Application : API Stability Enhancers, Coating Systems & Additives, Controlled & Modified Release, Direct Compression, Granulation, Rheology Modifiers, Vegetarian Capsules
Excipient Details : Controlled Release, Direct Compression,Wet Granulation,Tablet Coating, Liquid Solutions and Suspensions
Pharmacopoeia Ref : Not Available
Technical Specs : Not Available
Ingredient(s) : Hydroxypropyl Methyl Cellulose
Dosage Form : Tablet
Grade : Oral
Category : Coating Systems & Additives, Fillers, Diluents & Binders, Granulation
Dosage Form : Capsule, Emulsion, Softgel Capsule, Tablet
Grade : Not Available
Category : Film Formers & Plasticizers, Granulation, Solubilizers
Application : Film Formers & Plasticizers, Granulation, Solubilizers
Excipient Details : Solubiliser, Plasticizer for coating & polymeric matrices, Nonionic emulsifier for O-W emulsions.
Pharmacopoeia Ref : Ph. Eur: Macrogolglycerol Hydr...
Technical Specs : Not Available
Ingredient(s) : Polyoxyl 40 Hydrogenated Castor Oil
Dosage Form : Cream / Lotion / Ointment, Tablet
Grade : Oral, Topical
Category : Emulsifying Agents, Solubilizers
Brand Name : Polyoxyethylene Hydrogenated Castor Oil
Application : Emulsifying Agents, Solubilizers
Excipient Details : Polyoxyl 40 hydrogenated castor oil is used as a solubilizer and emulsifier in oral and topical formulations.
Pharmacopoeia Ref : ChP/USP/EP
Technical Specs : NA
Ingredient(s) : Polyoxyl 40 Hydrogenated Castor Oil
Dosage Form : Cream / Lotion / Ointment, Emulsion, Gel, Injectable / Parenteral, Suspension, Tablet
Grade : Parenteral, Oral, Topical
Category : Emulsifying Agents, Parenteral, Solubilizers, Surfactant & Foaming Agents, Thickeners and Stabilizers, Topical
Dosage Form : Injectable / Parenteral
Grade : Biopharma Grade
Category : Emulsifying Agents, Parenteral
Application : Emulsifying Agents, Parenteral
Excipient Details : Used as a fatty acid in cell culture media in upstream. Also used as an emulsifier and stabilizer in final formulation.
Pharmacopoeia Ref : On Request
Technical Specs : Low bacteria endotoxins, low bioburden (TAMC/TYMC). Customised pa...
Ingredient(s) : Oleic Acid Excipient
Dosage Form : Cream / Lotion / Ointment
Grade : Topical
Category : Emulsifying Agents, Film Formers & Plasticizers, Solubilizers, Thickeners and Stabilizers
Dosage Form : Injectable / Parenteral
Grade : Biopharma Grade
Category : Emulsifying Agents, Thickeners and Stabilizers
Application : Emulsifying Agents, Thickeners and Stabilizers
Excipient Details : Used as a fatty acid in cell culture media in upstream. Also used as an emulsifier and stabilizer in final formulation.
Pharmacopoeia Ref : On Request
Technical Specs : Low bacteria endotoxins, low bioburden (TAMC/TYMC). Customised pa...
Ingredient(s) : Stearic Acid
Dosage Form : Cream / Lotion / Ointment, Tablet
Grade : Oral, Topical
Category : Emulsifying Agents, Solubilizers
Dosage Form : Cream / Lotion / Ointment
Grade : Topical
Category : Emulsifying Agents, Solubilizers, Topical
Dosage Form : Capsule, Cream / Lotion / Ointment, Emulsion, Gel, Injectable / Parenteral, Suspension, Tablet
Grade : Parenteral, Oral, Topical
Category : Emulsifying Agents, Film Formers & Plasticizers, Parenteral, Solubilizers, Surfactant & Foaming Agents, Thickeners and Stabilizers, Topical
Application : Emulsifying Agents, Film Formers & Plasticizers, Parenteral, Solubilizers, Surfactant & Foaming Agents, Thickeners and Stabilizers, Topical
Excipient Details : Polysorbate 80 is used as a plasticizer, solubilizer, emulsifier, surfactant, and suspension stabilizer. It is also used in parenteral products.
Dosage Form : Emulsion, Injectable / Parenteral
Grade : Parenteral, Topical
Category : Emulsifying Agents, Parenteral, Topical
Dosage Form : Tablet
Grade : Oral
Category : Chewable & Orodispersible Aids, Co-Processed Excipients, Direct Compression, Taste Masking
Dosage Form : Capsule, Orodispersible Tablet, Tablet
Grade : Oral
Category : Chewable & Orodispersible Aids, Coating Systems & Additives, Fillers, Diluents & Binders
Dosage Form : Orodispersible Tablet, Tablet
Grade : Oral
Category : Chewable & Orodispersible Aids, Direct Compression, Fillers, Diluents & Binders, Taste Masking
Dosage Form : Tablet, Orodispersible Tablet
Grade : Oral
Category : Chewable & Orodispersible Aids, Co-Processed Excipients, Direct Compression, Disintegrants & Superdisintegrants, Fillers, Diluents & Binders, Taste Masking
Application : Chewable & Orodispersible Aids, Co-Processed Excipients, Direct Compression, Disintegrants & Superdisintegrants, Fillers, Diluents & Binders, Taste Masking
Excipient Details : Advantol® 300 is a DC pharmaceutical excipient used to create soft chew or fast melt oral dosage forms through co-processing technology.
Dosage Form : Orodispersible Tablet, Tablet
Grade : Oral
Category : Chewable & Orodispersible Aids, Taste Masking
Dosage Form : Tablet, Orodispersible Tablet
Grade : Oral
Category : Chewable & Orodispersible Aids, Co-Processed Excipients, Direct Compression, Fillers, Diluents & Binders, Taste Masking
Application : Chewable & Orodispersible Aids, Co-Processed Excipients, Direct Compression, Fillers, Diluents & Binders, Taste Masking
Excipient Details : Compressol® SM, co-processed polyol, is a DC excipient of mannitol & sorbitol with superior compactibility, low disintegration time & hygroscopicity.
Dosage Form : Orodispersible Tablet, Tablet
Grade : Oral
Category : Chewable & Orodispersible Aids, Disintegrants & Superdisintegrants, Fillers, Diluents & Binders
Brand Name : Mannogem XL Mannitol
Application : Chewable & Orodispersible Aids, Disintegrants & Superdisintegrants, Fillers, Diluents & Binders
Excipient Details : Mannogem® XL is a DC spray-dried mannitol used to enhance mannitol formulation tabletability & provide superior binding & quick disintegration.
Dosage Form : Orodispersible Tablet, Tablet
Grade : Oral
Category : Chewable & Orodispersible Aids, Direct Compression
Dosage Form : Orodispersible Tablet, Tablet
Grade : Oral
Category : Chewable & Orodispersible Aids, Direct Compression, Disintegrants & Superdisintegrants
Brand Name : Mannogem Granular
Application : Chewable & Orodispersible Aids, Direct Compression, Disintegrants & Superdisintegrants
Excipient Details : Mannogem Granular has larger particles, offering a softer texture for chewable tablets and excellent flow, disintegration, and compression properties.
Dosage Form : Tablet
Grade : Oral
Category : Chewable & Orodispersible Aids, Co-Processed Excipients, Direct Compression, Taste Masking
Grade : Oral
Category : Co-Processed Excipients, Fillers, Diluents & Binders
Application : Co-Processed Excipients, Fillers, Diluents & Binders
Excipient Details : ProBlend (SMCC) is a co-processed excipient consists of microcrystalline cellulose & colloidal silicon dioxide, used as a diluent & binder in OSDs.
Pharmacopoeia Ref : USP-NF,BP,EP,IP
Technical Specs : NA
Ingredient(s) : Microcrystalline Cellulose Excipients
Application : Co-Processed Excipients, Fillers, Diluents & Binders
Excipient Details : Microlose (Lactose Monohydrate & Microcrystalline Cellulose) is used as a diluent in oral dosage forms such as tablets.
Pharmacopoeia Ref : USP-NF,BP,EP,IP
Technical Specs : Lactose Monohydrate – 40%, Microcrystalline cellulose – 60%
Ingredient(s) : Lactose Monohydrate
Dosage Form : Tablet, Orodispersible Tablet
Grade : Oral
Category : Chewable & Orodispersible Aids, Co-Processed Excipients, Direct Compression, Disintegrants & Superdisintegrants, Fillers, Diluents & Binders, Taste Masking
Application : Chewable & Orodispersible Aids, Co-Processed Excipients, Direct Compression, Disintegrants & Superdisintegrants, Fillers, Diluents & Binders, Taste Masking
Excipient Details : Advantol® 300 is a DC pharmaceutical excipient used to create soft chew or fast melt oral dosage forms through co-processing technology.
Dosage Form : Tablet, Orodispersible Tablet
Grade : Oral
Category : Chewable & Orodispersible Aids, Co-Processed Excipients, Direct Compression, Fillers, Diluents & Binders, Taste Masking
Application : Chewable & Orodispersible Aids, Co-Processed Excipients, Direct Compression, Fillers, Diluents & Binders, Taste Masking
Excipient Details : Compressol® SM, co-processed polyol, is a DC excipient of mannitol & sorbitol with superior compactibility, low disintegration time & hygroscopicity.
Dosage Form : Tablet, Orodispersible Tablet
Grade : Oral
Category : Chewable & Orodispersible Aids, Co-Processed Excipients, Taste Masking
Application : Chewable & Orodispersible Aids, Co-Processed Excipients, Taste Masking
Excipient Details : HiCel CE15 offers a superior mouthfeel with less chalkiness and gritness in chewable tablets and orally disintegrating tablets (ODTs).
Pharmacopoeia Ref : Not Available
Technical Specs : Not Available
Ingredient(s) : Guar Gum Excipient
Brand Name : HiCel MCC Spheres
Application : Co-Processed Excipients, Controlled & Modified Release
Excipient Details : HiCel MCC Spheres are extremely versatile which are used for controlled release or sustained release formulations.
Pharmacopoeia Ref : Not Available
Technical Specs : Not Available
Ingredient(s) : Microcrystalline Cellulose Excipients
Dosage Form : Tablet
Grade : Oral
Category : Co-Processed Excipients, Direct Compression, Fillers, Diluents & Binders, Lubricants & Glidants
Application : Co-Processed Excipients, Direct Compression, Fillers, Diluents & Binders, Lubricants & Glidants
Excipient Details : HiCel SMCC has unique combination which result in optimum compaction & superior flow properties.
Pharmacopoeia Ref : Not Available
Technical Specs : Not Available
Ingredient(s) : Microcrystalline Cellulose Excipients
Dosage Form : Cream / Lotion / Ointment, Emulsion, Gel, Injectable / Parenteral, Suspension, Tablet
Grade : Parenteral, Oral, Topical
Category : Emulsifying Agents, Parenteral, Solubilizers, Surfactant & Foaming Agents, Thickeners and Stabilizers, Topical
Dosage Form : Injectable / Parenteral
Grade : Biopharma Grade
Category : Parenteral, Surfactant & Foaming Agents
Application : Parenteral, Surfactant & Foaming Agents
Excipient Details : Used as surfactant agent in cell culture media, in protein purification and in injectable formulations.
Pharmacopoeia Ref : On Request
Technical Specs : Low bacteria endotoxins, low bioburden (TAMC/TYMC). Customised pa...
Ingredient(s) : Tween 20 Excipient
Dosage Form : Emulsion
Grade : Topical
Category : Emulsifying Agents, Surfactant & Foaming Agents, Topical
Dosage Form : Injectable / Parenteral
Grade : Biopharma Grade
Category : Parenteral, Surfactant & Foaming Agents
Application : Parenteral, Surfactant & Foaming Agents
Excipient Details : Used as surfactant agent in cell culture media, in protein purification and in injectable formulations.
Pharmacopoeia Ref : On Request
Technical Specs : Low bacteria endotoxins, low bioburden (TAMC/TYMC). Customised pa...
Ingredient(s) : Polysorbate 80
Dosage Form : Capsule, Cream / Lotion / Ointment, Emulsion, Gel, Injectable / Parenteral, Suspension, Tablet
Grade : Parenteral, Oral, Topical
Category : Emulsifying Agents, Film Formers & Plasticizers, Parenteral, Solubilizers, Surfactant & Foaming Agents, Thickeners and Stabilizers, Topical
Application : Emulsifying Agents, Film Formers & Plasticizers, Parenteral, Solubilizers, Surfactant & Foaming Agents, Thickeners and Stabilizers, Topical
Excipient Details : Polysorbate 80 is used as a plasticizer, solubilizer, emulsifier, surfactant, and suspension stabilizer. It is also used in parenteral products.
Grade : Oral
Category : Film Formers & Plasticizers, Surfactant & Foaming Agents, Taste Masking
Dosage Form : Cream / Lotion / Ointment, Emulsion, Gel, Suspension
Grade : Topical, Oral
Category : Emulsifying Agents, Solubilizers, Surfactant & Foaming Agents, Thickeners and Stabilizers, Topical
Dosage Form : Cream / Lotion / Ointment, Gel, Injectable / Parenteral, Softgel Capsule, Softgels
Grade : Parenteral, Topical, Oral
Category : Fillers, Diluents & Binders, Film Formers & Plasticizers, Parenteral, Surfactant & Foaming Agents, Thickeners and Stabilizers, Topical
Brand Name : Polyethylene Glycol 400
Application : Fillers, Diluents & Binders, Film Formers & Plasticizers, Parenteral, Surfactant & Foaming Agents, Thickeners and Stabilizers, Topical
Excipient Details : PEG 400 is used as a suspending agent, stabilizer, plasticizer and filler in OSDs, liquids & semi-solids and as a solvent for parenteral formulations.
Dosage Form : Tablet
Grade : Oral
Category : Granulation, Lubricants & Glidants, Surfactant & Foaming Agents
Dosage Form : Injectable / Parenteral, Tablet
Grade : Oral & Parenteral
Category : Emulsifying Agents, Solubilizers, Surfactant & Foaming Agents
Application : Emulsifying Agents, Solubilizers, Surfactant & Foaming Agents
Excipient Details : Polysorbate 20 is widely used as a surfactant, emulsifier, solubilizer, and stabilizer.
Dosage Form : Cream / Lotion / Ointment, Emulsion, Orodispersible Tablet
Grade : Oral, Topical
Category : Disintegrants & Superdisintegrants, Topical
Application : Disintegrants & Superdisintegrants, Topical
Excipient Details : Glycine is used as a disintegrant in solid dosage forms such as orally disintegrating tablets and in topical formulations such as emulsions & creams.
Pharmacopoeia Ref : NA
Technical Specs : Molecular weight: 75.07 g/mol
Ingredient(s) : Glycine Excipient
Dosage Form : Tablet, Orodispersible Tablet
Grade : Oral
Category : Chewable & Orodispersible Aids, Co-Processed Excipients, Direct Compression, Disintegrants & Superdisintegrants, Fillers, Diluents & Binders, Taste Masking
Application : Chewable & Orodispersible Aids, Co-Processed Excipients, Direct Compression, Disintegrants & Superdisintegrants, Fillers, Diluents & Binders, Taste Masking
Excipient Details : Advantol® 300 is a DC pharmaceutical excipient used to create soft chew or fast melt oral dosage forms through co-processing technology.
Application : Parenteral
Excipient Details : Used as an ingredient in cell culture media in upstream, as a buffer elution in downstream and as a buffering agent in formulations.
Pharmacopoeia Ref : On Request
Technical Specs : Low bacteria endotoxins, low bioburden (TAMC/TYMC). Customised pa...
Ingredient(s) : Glycine Excipient
Dosage Form : Orodispersible Tablet, Tablet
Grade : Oral
Category : Chewable & Orodispersible Aids, Disintegrants & Superdisintegrants, Fillers, Diluents & Binders
Brand Name : Mannogem XL Mannitol
Application : Chewable & Orodispersible Aids, Disintegrants & Superdisintegrants, Fillers, Diluents & Binders
Excipient Details : Mannogem® XL is a DC spray-dried mannitol used to enhance mannitol formulation tabletability & provide superior binding & quick disintegration.
Dosage Form : Orodispersible Tablet, Tablet
Grade : Oral
Category : Chewable & Orodispersible Aids, Direct Compression, Disintegrants & Superdisintegrants
Brand Name : Mannogem Granular
Application : Chewable & Orodispersible Aids, Direct Compression, Disintegrants & Superdisintegrants
Excipient Details : Mannogem Granular has larger particles, offering a softer texture for chewable tablets and excellent flow, disintegration, and compression properties.
Application : Direct Compression, Disintegrants & Superdisintegrants
Excipient Details : Mannogem 2080 exhibits excellent flow, disintegration and compression properties.
Brand Name : Hydroxypropyl Methyl Cellulose
Application : Coating Systems & Additives
Pharmacopoeia Ref : Not Available
Technical Specs : Not Available
Ingredient(s) : Hydroxypropyl Methyl Cellulose
Dosage Form : Emulsion, Tablet
Grade : Oral, Ophthalmic
Category : Disintegrants & Superdisintegrants, Emulsifying Agents, Film Formers & Plasticizers, Thickeners and Stabilizers
Brand Name : Hydroxypropyl Methyl Cellulose
Application : Disintegrants & Superdisintegrants, Emulsifying Agents, Film Formers & Plasticizers, Thickeners and Stabilizers
Excipient Details : Hydroxypropyl Methyl Cellulose is used as a film-former, disintegrant, thickener, and emulsifier in tablets, emulsions, and ophthalmic formulations.
Brand Name : Microcrystalline Cellulose
Application : Fillers, Diluents & Binders
Excipient Details : Microcrystalline Cellulose is most commonly used filler and binder in drug formulations, together with Lactose.
Pharmacopoeia Ref : Not Available
Technical Specs : Not Available
Ingredient(s) : Microcrystalline Cellulose Excipients
Dosage Form : Capsule, Cream / Lotion / Ointment, Gel, Tablet
Grade : Topical, Oral
Category : Film Formers & Plasticizers, Lubricants & Glidants, Topical
Dosage Form : Capsule, Solution, Tablet
Grade : Oral
Category : API Stability Enhancers, Lubricants & Glidants
Application : API Stability Enhancers, Lubricants & Glidants
Excipient Details : Sodium Benzoate is used as a antimicrobial preservative in oral liquid dosage forms.
Pharmacopoeia Ref : Ph. Eur.|NF
Technical Specs : Not Available
Ingredient(s) : Sodium Benzoate Excipient
Dosage Form : Tablet
Grade : Oral
Category : Granulation, Lubricants & Glidants, Surfactant & Foaming Agents
Dosage Form : Granule / Pellet, Tablet
Grade : Oral & Topical
Category : Controlled & Modified Release, Lubricants & Glidants
Application : Controlled & Modified Release, Lubricants & Glidants
Excipient Details : Talc is a widely used as a dissolution retardant in the development of controlled release products. Talc is also used as a lubricant in tablet formulations.
Excipients Web Link
Dosage Form : Tablet
Grade : Oral
Category : Co-Processed Excipients, Direct Compression, Fillers, Diluents & Binders, Lubricants & Glidants
Application : Co-Processed Excipients, Direct Compression, Fillers, Diluents & Binders, Lubricants & Glidants
Excipient Details : HiCel SMCC has unique combination which result in optimum compaction & superior flow properties.
Pharmacopoeia Ref : Not Available
Technical Specs : Not Available
Ingredient(s) : Microcrystalline Cellulose Excipients
Dosage Form : Tablet
Grade : Topical, Oral
Category : Fillers, Diluents & Binders, Lubricants & Glidants
Application : Fillers, Diluents & Binders, Lubricants & Glidants
Pharmacopoeia Ref : Monograph- Ph.Eur, USP/NF, JP/...
Technical Specs : Not Available
Ingredient(s) : Stearic Acid
Grade : Not Available
Category : Direct Compression, Granulation, Lubricants & Glidants
Brand Name : Kolliphor SLS Fine
Application : Direct Compression, Granulation, Lubricants & Glidants
Excipient Details : Wetting agent, reducing disintegration time, direct compression, Hydrophilic lubricant, effervescent tablets.
Pharmacopoeia Ref : Ph. Eur.: Sodium Laurilsulfate...
Technical Specs : Not Available
Ingredient(s) : Sodium Lauryl Sulfate
Dosage Form : Tablet
Grade : Topical, Oral
Category : Fillers, Diluents & Binders, Lubricants & Glidants
Application : Fillers, Diluents & Binders, Lubricants & Glidants
Excipient Details : Stearic acid is a saturated, wax-like, fatty acid commonly used in the production of pharmaceutical tablets and capsules.
Pharmacopoeia Ref : Monograph- Ph.Eur, USP/NF, JP/...
Technical Specs : Not Available
Ingredient(s) : Stearic Acid
Dosage Form : Capsule, Cream / Lotion / Ointment, Emulsion, Tablet
Grade : Oral and Topical
Category : Controlled & Modified Release, Emulsifying Agents, Film Formers & Plasticizers, Lubricants & Glidants
Application : Controlled & Modified Release, Emulsifying Agents, Film Formers & Plasticizers, Lubricants & Glidants
Excipient Details : Acryflow S is used as an emulsifier for oil-in-water emulsions and as a pH independent sustained release agent.
Pharmacopoeia Ref : USP/NF: Hydrogenated Castor Oi...
Technical Specs : Not Available
Ingredient(s) : Hydrogenated Castor Oil
Application : Lubricants & Glidants
Excipient Details : Puretalc is used as a lubricant & diluent in oral solid dosage formulations such as tablets.
Application : Empty Capsules
Excipient Details : Quali-V®-I is the first plant-based capsule that responds to the particular functional properties required for use in dry powder inhaler (DPI) devices.
Pharmacopoeia Ref : Not Available
Technical Specs : Not Available
Ingredient(s) : Hydroxypropyl Methyl Cellulose
Application : Empty Capsules
Excipient Details : ACGCAPS™ GL / HL is available in gelatin and cellulose (HPMC) material options and can be used for liquids, semi-liquids, hot-melts and combination fills.
Excipients Web Link
Application : Empty Capsules
Excipient Details : ACGCAPS™ GR can fulfill immediate release needs and is available in 15 sizes (from # 000 to # 5).
Application : Empty Capsules
Excipient Details : ACGCAPS™ GC is specially designed for use in clinical trials and comes in the available sizes: AA, A & B.
Excipients Web Link
Application : Empty Capsules
Pharmacopoeia Ref : Certified Vegan, Non-GMO, Vege...
Technical Specs : Size # 00el - 4
Ingredient(s) : Gelatin Excipient
Dosage Form : Cream / Lotion / Ointment, Tablet, Capsule, Gel, Solution
Grade : Oral, Topical
Category : API Stability Enhancers
Dosage Form : Injectable / Parenteral
Grade : Parenteral
Category : Parenteral, Thickeners and Stabilizers
Application : Parenteral, Thickeners and Stabilizers
Excipient Details : L-Arginine is used as a cryoprotective agent and solution additive to stabilize proteins. It is used in injectable biologic & vaccine formulations.
Pharmacopoeia Ref : USP, EP, JP, ChP
Technical Specs : Low Endotoxin, Low Metals
Ingredient(s) : L-Arginine Excipient
Dosage Form : Injectable / Parenteral
Grade : Biopharma Grade
Category : API Stability Enhancers, Thickeners and Stabilizers
Application : API Stability Enhancers, Thickeners and Stabilizers
Excipient Details : Used to stabilize proteins in injectable biologic formulations. Also used as a nutrient for cell culture media in upstream.
Pharmacopoeia Ref : On Request
Technical Specs : Low bacteria endotoxins, low bioburden (TAMC/TYMC). Customised pa...
Ingredient(s) : L-Arginine Excipient
Brand Name : Citric Acid 1-Hydrate
Application : API Stability Enhancers
Excipient Details : Citric Acid 1-hydrate is used as a chelating and/or complexing agent in various oral liquid formulations.
Pharmacopoeia Ref : Ph. Eur.|USP
Technical Specs : Not Available
Ingredient(s) : Citric Acid Excipient
Dosage Form : Capsule, Solution, Tablet
Grade : Oral
Category : API Stability Enhancers, Lubricants & Glidants
Application : API Stability Enhancers, Lubricants & Glidants
Excipient Details : Sodium Benzoate is used as a antimicrobial preservative in oral liquid dosage forms.
Pharmacopoeia Ref : Ph. Eur.|NF
Technical Specs : Not Available
Ingredient(s) : Sodium Benzoate Excipient
Dosage Form : Injectable / Parenteral
Grade : Parenteral
Category : Parenteral, Thickeners and Stabilizers
Grade : Not Available
Category : API Stability Enhancers, Coating Systems & Additives, Controlled & Modified Release, Direct Compression, Granulation, Rheology Modifiers, Vegetarian Capsules
Application : API Stability Enhancers, Coating Systems & Additives, Controlled & Modified Release, Direct Compression, Granulation, Rheology Modifiers, Vegetarian Capsules
Excipient Details : Controlled Release, Direct Compression,Wet Granulation,Tablet Coating, Liquid Solutions and Suspensions
Pharmacopoeia Ref : Not Available
Technical Specs : Not Available
Ingredient(s) : Hydroxypropyl Methyl Cellulose
Dosage Form : Capsule
Grade : Oral and Inhalation
Category : API Stability Enhancers, Vegetarian Capsules
Application : API Stability Enhancers, Vegetarian Capsules
Pharmacopoeia Ref : Certified Vegan, Non-GMO, Vege...
Technical Specs : "Water content – less than 9%, can be customized; Size # 00el -...
Ingredient(s) : Hydroxypropyl Methyl Cellulose
Dosage Form : Capsule
Grade : Oral
Category : API Stability Enhancers, Taste Masking, Vegetarian Capsules
Application : API Stability Enhancers, Taste Masking, Vegetarian Capsules
Pharmacopoeia Ref : Certified Vegan, Non-GMO, Vege...
Technical Specs : Size # 0-1
Ingredient(s) : Hydroxypropyl Methyl Cellulose
Dosage Form : Capsule, Tablet, Dry Syrup
Grade : Oral
Category : Co-Processed Excipients, Direct Compression, Solubilizers
Application : Co-Processed Excipients, Direct Compression, Solubilizers
Excipient Details : Solubilizer
Pharmacopoeia Ref : Not Available
Technical Specs : Solubilizer in powder form; EXCiPACT
Ingredient(s) : Polyoxyl 40 Hydrogenated Castor Oil
Dosage Form : Cream / Lotion / Ointment, Emulsion
Grade : Topical
Category : Coating Systems & Additives, Rheology Modifiers, Topical
Application : Coating Systems & Additives, Rheology Modifiers, Topical
Excipient Details : Polyglykol 400 is a liquid PEG excipient grade product which is used as solvent, humectant, coating agent and viscosity enhancer.
Pharmacopoeia Ref : USP-NF: Polyethylene glycol 40...
Technical Specs : average molar mass 400 g/mol
Ingredient(s) : Polyethylene Glycol 400
Grade : Not Available
Category : API Stability Enhancers, Coating Systems & Additives, Controlled & Modified Release, Direct Compression, Granulation, Rheology Modifiers, Vegetarian Capsules
Application : API Stability Enhancers, Coating Systems & Additives, Controlled & Modified Release, Direct Compression, Granulation, Rheology Modifiers, Vegetarian Capsules
Excipient Details : Controlled Release, Direct Compression,Wet Granulation,Tablet Coating, Liquid Solutions and Suspensions
Pharmacopoeia Ref : Not Available
Technical Specs : Not Available
Ingredient(s) : Hydroxypropyl Methyl Cellulose
Dosage Form : Cream / Lotion / Ointment, Emulsion
Grade : Topical
Category : Coating Systems & Additives, Rheology Modifiers, Topical
Application : Coating Systems & Additives, Rheology Modifiers, Topical
Excipient Details : Polyglykol 600 is a liquid PEG excipient grade product which is used as solvent, humectant, coating agent and viscosity enhancer.
Pharmacopoeia Ref : USP-NF: Polyethylene glycol 60...
Technical Specs : average molar mass 600 g/mol
Ingredient(s) : Polyethylene Glycol 600
Dosage Form : Tablet, Emulsion, Suspension
Grade : Oral
Category : Co-Processed Excipients, Fillers, Diluents & Binders, Rheology Modifiers
Application : Co-Processed Excipients, Fillers, Diluents & Binders, Rheology Modifiers
Excipient Details : HiCel MCG is use in oral suspensions as a stabilizer. It is a good binder for tablets & excellent thickener as well.
Pharmacopoeia Ref : Not Available
Technical Specs : Not Available
Ingredient(s) : Carboxymethyl Cellulose Sodium
Dosage Form : Cream / Lotion / Ointment, Emulsion, Gel
Grade : Oral and Topical
Category : Rheology Modifiers, Topical
Application : Rheology Modifiers, Topical
Excipient Details : Acrypol 974P acts as rheology modifiers in cream, lotion, gel, oral suspension, transdermal gel reservoirs etc.
Pharmacopoeia Ref : USP/NF : Carbomer Homopolymer ...
Technical Specs : Not Available
Ingredient(s) : Carbomer 934
Dosage Form : Cream / Lotion / Ointment, Emulsion, Gel
Grade : Topical
Category : Rheology Modifiers, Thickeners and Stabilizers, Topical
Application : Rheology Modifiers, Thickeners and Stabilizers, Topical
Excipient Details : Thickener, Stabilizer / Emulsifier, Texturizing Agent
Dosage Form : Cream / Lotion / Ointment, Emulsion
Grade : Topical
Category : Emulsifying Agents, Rheology Modifiers, Thickeners and Stabilizers, Topical
Application : Emulsifying Agents, Rheology Modifiers, Thickeners and Stabilizers, Topical
Excipient Details : Thickener, Emulsifier, Stabilizer, Texturizing agent, pH Independent & Non Thixotropic polymer for Topical Range (Skin,Vaginal & Anal mucosa)
Pharmacopoeia Ref : In house having US DMF Type IV...
Technical Specs : Ready to use liquid polymer for topical applications (Gel / Cream...
Ingredient(s) : Hydroxyethyl Acrylate
Grade : Not Available
Category : API Stability Enhancers, Coating Systems & Additives, Controlled & Modified Release, Direct Compression, Granulation, Rheology Modifiers, Vegetarian Capsules
Application : API Stability Enhancers, Coating Systems & Additives, Controlled & Modified Release, Direct Compression, Granulation, Rheology Modifiers, Vegetarian Capsules
Excipient Details : Controlled Release, Direct Compression,Wet Granulation,Tablet Coating, Liquid Solutions and Suspensions
Pharmacopoeia Ref : Not Available
Technical Specs : Not Available
Ingredient(s) : Hydroxypropyl Methyl Cellulose
Dosage Form : Capsule
Grade : Oral and Inhalation
Category : API Stability Enhancers, Vegetarian Capsules
Application : API Stability Enhancers, Vegetarian Capsules
Pharmacopoeia Ref : Certified Vegan, Non-GMO, Vege...
Technical Specs : "Water content – less than 9%, can be customized; Size # 00el -...
Ingredient(s) : Hydroxypropyl Methyl Cellulose
Application : Controlled & Modified Release, Vegetarian Capsules
Pharmacopoeia Ref : Complies with relevant Europea...
Technical Specs : Water content – less than 6%; Size #0
Ingredient(s) : Hypromellose Acetate Succinate
Dosage Form : Capsule
Grade : Oral
Category : API Stability Enhancers, Taste Masking, Vegetarian Capsules
Application : API Stability Enhancers, Taste Masking, Vegetarian Capsules
Pharmacopoeia Ref : Certified Vegan, Non-GMO, Vege...
Technical Specs : Size # 0-1
Ingredient(s) : Hydroxypropyl Methyl Cellulose
Dosage Form : Granule / Pellet, Tablet
Grade : Oral
Category : Coating Systems & Additives, Coloring Agents
Brand Name : SEPIFILM Classic Range
Application : Coating Systems & Additives, Coloring Agents
Excipient Details : Coating
Dosage Form : Granule / Pellet, Tablet
Grade : Oral
Category : Coating Systems & Additives, Coloring Agents
Brand Name : SEPIFILM PW Range
Application : Coating Systems & Additives, Coloring Agents
Excipient Details : Coating
https://www.pharmacompass.com/radio-compass-blog/fda-s-december-2025-opoe-list-features-784-prescription-drugs-73-otc-drugs

26 Jan 2026
// PR NEWSWIRE
https://www.prnewswire.com/news-releases/lunai-bioworks-nasdaq-lnai-expands-nih-funded-ai-program-into-commercial-alcohol-use-disorder-drug-discovery-302670067.html

23 Oct 2025
// FDA
https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=214988

21 Jul 2025
// BUSINESSWIRE
https://www.businesswire.com/news/home/20250721261120/en/Avenacy-Announces-Launch-of-Dehydrated-Alcohol-Injection-USP-Vials-in-the-U.S.-Market

09 Jul 2025
// FDA
https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=219569

27 Jun 2025
// GLOBENEWSWIRE
https://www.globenewswire.com/news-release/2025/06/27/3106579/0/en/Clearmind-Medicine-Expands-Global-Clinical-Trial-Targeting-Multibillion-Dollar-Alcohol-Use-Disorder-Market.html

25 Jun 2025
// PR NEWSWIRE
https://www.prnewswire.com/news-releases/accord-healthcare-launches-dehydrated-alcohol-injection-for-cardiovascular-indications-302490056.html
Market Place
Reply
18 Apr 2023
Reply
27 Jun 2022
Reply
23 May 2022
Reply
05 Aug 2021
Reply
08 Feb 2020
Reply
14 Oct 2019
Reply
17 Aug 2018
Reply
19 Jul 2017
FULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]
Reply
27 Mar 2026
Reply
06 Oct 2025
Reply
11 Apr 2025
Reply
13 Sep 2023
Reply
16 Jun 2023
Reply
15 May 2023
Reply
18 Jan 2023
Reply
11 Oct 2022
Reply
06 Sep 2022
FULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]
Reply
24 Feb 2023
Reply
20 Oct 2021
Reply
27 Feb 2021
Reply
07 Mar 2020
Reply
05 Feb 2019
Reply
25 Jan 2019
FULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]
REF. STANDARDS & IMPURITIES
CAS Number : n/a
Quantity Per Vial : 260 mg
Sale Unit : 1
Order Code : P2920000
Batch No : 7
Price (€) : 79
Storage : -20°C ± 5°C

CAS Number : 57-88-5
Quantity Per Vial : 100 mg
Sale Unit : 1
Order Code : C2155000
Batch No : 4
Price (€) : 79
Storage : +5°C ± 3°C

FULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]
Sigma-Aldrich empowers scientific discovery with top-quality solutions to accelerate research, innovation, and better health worldwide.
CAS Number :
Quantity Per Vial :
Sale Unit :
Price : $153.00
Details :
Monograph : PHR2599-1G
Storage : +2°C to +30°C
Code/Batch No :
Sigma-Aldrich empowers scientific discovery with top-quality solutions to accelerate research, innovation, and better health worldwide.
CAS Number : 60-12-8
Quantity Per Vial :
Sale Unit :
Price : $111.00
Details :
Monograph : PHR1122-1.5G
Storage : +2°C to +30°C
Code/Batch No :
Sigma-Aldrich empowers scientific discovery with top-quality solutions to accelerate research, innovation, and better health worldwide.
CAS Number : 60-12-8
Quantity Per Vial :
Sale Unit :
Price : $132.00
Details :
Monograph : PHR1122-2G
Storage : +2°C to +30°C
Code/Batch No :
FULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]ANALYTICAL
Product Code : CR30S05-2546WT
Classification : Optical isomers
Product Characteristics : N050823A
Category :
Description :

Product Code : NR30S05-2546WT
Classification : Optical isomers
Product Characteristics : N050823B
Category :
Description :

Product Code : CR30S05-2546WT
Classification : Optical isomers
Product Characteristics : N050819C
Category :
Description :

ABOUT THIS PAGE
97
PharmaCompass offers a list of Ethanol API manufacturers, exporters & distributors, which can be sorted by GMP, USDMF, JDMF, KDMF, CEP (COS), WC, and more, enabling you to easily find the right Ethanol manufacturer or Ethanol supplier for your needs.
Send us enquiries for free, and we will assist you in establishing a direct connection with your preferred Ethanol manufacturer or Ethanol supplier.
A Lux manufacturer is defined as any person or entity involved in the manufacture, preparation, processing, compounding or propagation of Lux, including repackagers and relabelers. The FDA regulates Lux manufacturers to ensure that their products comply with relevant laws and regulations and are safe and effective to use. Lux API Manufacturers are required to adhere to Good Manufacturing Practices (GMP) to ensure that their products are consistently manufactured to meet established quality criteria.
click here to find a list of Lux manufacturers with USDMF, JDMF, KDMF, CEP, GMP, and COA related information on PhamaCompass.
A Lux supplier is an individual or a company that provides Lux active pharmaceutical ingredient (API) or Lux finished formulations upon request. The Lux suppliers may include Lux API manufacturers, exporters, distributors and traders.
click here to find a list of Lux suppliers with USDMF, JDMF, KDMF, CEP, GMP, and COA related information on PharmaCompass.
A Lux DMF (Drug Master File) is a document detailing the whole manufacturing process of Lux active pharmaceutical ingredient (API) in detail. Different forms of Lux DMFs exist exist since differing nations have different regulations, such as Lux USDMF, ASMF (EDMF), JDMF, CDMF, etc.
A Lux DMF submitted to regulatory agencies in the US is known as a USDMF. Lux USDMF includes data on Lux's chemical properties, information on the facilities and procedures used, and details about packaging and storage. The Lux USDMF is kept confidential to protect the manufacturer’s intellectual property.
click here to find a list of Lux suppliers with USDMF on PharmaCompass.
The Pharmaceuticals and Medical Devices Agency (PMDA) established the Japan Drug Master File (JDMF), also known as the Master File (MF), to permit Japanese and foreign manufacturers of drug substances, intermediates, excipients, raw materials, and packaging materials (‘Products’) to voluntarily register confidential information about the production and management of their products in Japan.
The Lux Drug Master File in Japan (Lux JDMF) empowers Lux API manufacturers to present comprehensive information (e.g., production methods, data, etc.) to the review authority, i.e., PMDA (Pharmaceuticals & Medical Devices Agency).
PMDA reviews the Lux JDMF during the approval evaluation for pharmaceutical products. At the time of Lux JDMF registration, PMDA checks if the format is accurate, if the necessary items have been included (application), and if data has been attached.
click here to find a list of Lux suppliers with JDMF on PharmaCompass.
In Korea, the Ministry of Food and Drug Safety (MFDS) is in charge of regulating pharmaceutical products and services.
Pharmaceutical companies submit a Lux Drug Master File in Korea (Lux KDMF) to the MFDS, which includes comprehensive information about the production, processing, facilities, materials, packaging, and testing of Lux. The MFDS reviews the Lux KDMF as part of the drug registration process and uses the information provided in the Lux KDMF to evaluate the safety and efficacy of the drug.
After submitting a Lux KDMF to the MFDS, the registered manufacturer can provide importers or distributors with the registration number without revealing confidential information to Korean business partners. Applicants seeking to register their Lux API can apply through the Korea Drug Master File (KDMF).
click here to find a list of Lux suppliers with KDMF on PharmaCompass.
A Lux CEP of the European Pharmacopoeia monograph is often referred to as a Lux Certificate of Suitability (COS). The purpose of a Lux CEP is to show that the European Pharmacopoeia monograph adequately controls the purity of Lux EP produced by a given manufacturer. Suppliers of raw materials can prove the suitability of Lux to their clients by showing that a Lux CEP has been issued for it. The manufacturer submits a Lux CEP (COS) as part of the market authorization procedure, and it takes on the role of a Lux CEP holder for the record. Additionally, the data presented in the Lux CEP (COS) is managed confidentially and offers a centralized system acknowledged by numerous nations, exactly like the Lux DMF.
A Lux CEP (COS) is recognised by all 36 nations that make up the European Pharmacopoeia Convention. Lux CEPs may be accepted in nations that are not members of the Ph. Eur. at the discretion of the authorities there.
click here to find a list of Lux suppliers with CEP (COS) on PharmaCompass.
Lux Active pharmaceutical ingredient (API) is produced in GMP-certified manufacturing facility.
GMP stands for Good Manufacturing Practices, which is a system used in the pharmaceutical industry to make sure that goods are regularly produced and monitored in accordance with quality standards. The FDA’s current Good Manufacturing Practices requirements are referred to as cGMP or current GMP which indicates that the company follows the most recent GMP specifications. The World Health Organization (WHO) has its own set of GMP guidelines, called the WHO GMP. Different countries can also set their own guidelines for GMP like China (Chinese GMP) or the EU (EU GMP).
PharmaCompass offers a list of Lux GMP manufacturers, exporters & distributors, which can be sorted by USDMF, JDMF, KDMF, CEP (COS), WC, and more, enabling you to easily find the right Lux GMP manufacturer or Lux GMP API supplier for your needs.
A Lux CoA (Certificate of Analysis) is a formal document that attests to Lux's compliance with Lux specifications and serves as a tool for batch-level quality control.
Lux CoA mostly includes findings from lab analyses of a specific batch. For each Lux CoA document that a company creates, the USFDA specifies specific requirements, such as supplier information, material identification, transportation data, evidence of conformity and signature data.
Lux may be tested according to a variety of international standards, such as European Pharmacopoeia (Lux EP), Lux JP (Japanese Pharmacopeia) and the US Pharmacopoeia (Lux USP).